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ABSTRACT
Graphene-based nanomaterials are novel emerging materials with their
superior physical, chemical and mechanical features that have applications in a broad
diversity of fields. Their excellent properties include: 1) Superior biocompatibility
compared to the traditional QDs because they are free from toxic heavy metals. 2) Large
surface area and easy covalent/chemical modification which makes them convenient as
drug delivery carriers, in comparison with liposomes. 3) High light absorption in the
near infrared (NIR) region. Compared to metal nanoparticles, which gives them better
photothermal

properties.

4)

Strong

quenching

efficiency;

graphene-based

nanomaterials were able to quench various fluorophores through fluorescence
resonance energy transfer (FRET). 5) Biofunctionalization; graphene-based materials
display excellent capabilities for direct binding with biomolecules. Considering these
significant properties, this dissertation work focuses on the development of graphenebased nanomaterials and applications of these nanomaterials in different fields. A total
of four projects are presented.
In the first project, a multi-modal therapeutic drug delivery system was
developed for cancer therapy. A reduced graphene oxide coated with mesoporous silica
(rGO@msilica) nanocarrier was designed for chemo-photothermal therapeutic capacity.
The inner layer of the rGO served as a photothermal agent while the outer layer of the
mesoporous silica acted as a pH-trigged drug carrier. Doxorubicin (DOX) was loaded
into the mesoporous silica vehicle was a chemotherapy agent. In the acidic environment,
DOX was gradually released from the nanocarrier to fulfill the chemotherapeutic
function. Meanwhile, rGO@msilica showed a strong photothermal (PTT) effect under
xvii

a NIR irradiation, generating synergistic therapeutic efficiency for destroying cancer
cells.
In the second project, a “turn-on” fluorescence method was developed for
monitoring exonuclease III enzymatic activity based on the interaction between
graphene oxide (GO) and a DNA hairpin probe (HP). In the absence of Exo III, the
strong π-π interaction between the fluorophore-tagged DNA and GO caused efficient
fluorescence quenching via FRET. In the presence of Exo III, the fluorophore tagged
3’-hydroxyl termini of DNA probe was digested to set the fluorophore free from
adsorption by GO, causing less fluorescence quenching. This simple GO-based probe
showed highly sensitive and selective linear response in the low detection range from
0.01 U/mL to 0.5 U/mL and with a limit of detection (LOD) of 0.001 U/mL. Compared
with other fluorescent probes, this assay exhibited superior sensitivity and selectivity
in both buffer and fetal bovine serum samples. The assay was also low cost and easy to
set up.
In the third project, humic acid, a new carbon source was used to fabricate
graphene quantum dots (GQDs) by an easy one pot hydrothermal reaction. The
morphology of the blue emission graphene quantum dots was characterized by high
resolution transmission electron microscopy (HRTEM) and dynamic light scattering
(DLS). The results showed crystalline lattice spacing of 0.286 nm and a hydrodynamic
diameter of 6.6 nm. X-ray photoelectron spectroscopy (XPS) and FT-IR have
demonstrated diverse functional groups on the GQDs, which yielded strong chelating
interactions with Cu2+. The optical properties of GQDs were characterized by
photoluminescence (PL) spectra and ultraviolet-visible (UV-Vis) spectroscopy. Both
showed that the GQDs had an excitation-dependent fluorescence behavior and a large
stoke shift with maximum excitation/emission wavelength at 340/470 nm. These
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properties will provide a useful signal for fluorometric methods of analysis.
Furthermore, the GQDs showed a good photostability and a relative high quantum yield
of 20%, which is adequate to serve as a bioimaging probe. Metal ion selectivity studies
indicated that the GQDs could be applied as Cu2+ sensing nanoprobe for drinking water
in the linear range from 1 M to 40 M and a low LOD of 0.44 M. Overall, this work
provided a simple method to produce GQDs as well as a Cu2+ sensing nanoprobe with
low cost raw materials humic acid, which would be a great improvement in biomedical
fields.
In the fourth project, Eu3+ coordinated polymer nanoparticles based on poly[2methoxy-5-(2-ethylhexyloxy)-1,4-phenylenevinylene] (MEH PPV-Eu) were developed
and used for Cu2+

detection. The designed MEH PPV-Eu probe has both fluorescence

signal from the conjugated polymer and the Eu signal detected by spICP-MS. Cu2+
were proven to have efficient chelating interactions with carboxylic groups, which
resulted in a significant fluorescence quenching due to aggregation. The aggregation
increased the Eu intensity per particle and was also quantified by single-particle
inductively coupled plasma mass spectrometry (spICP-MS). For the fluorometric
method, it obtained a linear range from 2 M to 50 M and a LOD of 0.29 M. For the
spICP-MS method, it achieved a lower LOD of 0.42 pM and a wider linear range from
1.0×10-3 nM to 1.0×104 nM. This combination assay will provide a rapid and fast
approach with an extremely low detection limit, indicating its superior potential in
environmental analysis.
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CHAPTER I
REDUCED GRAPHENE OXIDE/MESOPOROUS SILICA NANOPARTICLES FOR
pH-TRIGGERED DRUG RELEASE AND PHOTOTHERMAL THERAPY
1. Introduction
Cancer is a terrifying health threat to human beings worldwide.1 Up to now,
multiple therapeutic strategies have been developed. Chemotherapy, which uses drugs
to attack tumor cells, has been widely applied. However, non-specific drug delivery
causes considerable side effects to patients, which limits their applications.2 Therefore,
it is urgent to develop a controllable drug release system that effectively targets
malignant tissue regions.3 Traditional drug carriers have relied on blood circulation to
proceed the medication process, which is a passive and lacks specificity.4 Nowadays,
active drug delivery systems are being developed to respond to certain environmental
stimuli, such as light, pH, and thermalization.5-9 Compared with passive drug carriers,
active carriers have controllable loading and releasing systems which response to
internal or external stimulations. As a result, the drug targeting efficiency has been
enhanced significantly and healthy cells have been protected.3
Among the stimuli used for active drug release, the pH-responsive drug
delivery system shows promising functions in the field of chemotherapy.10 In general,
cancer cells have a feature of unlimited proliferation; thus, they contribute to overoxygen consumption and an acidic microenvironment compared to healthy tissues.11-12
The lower pH value can be utilized as a stimulus to design active drug delivery carriers
for chemotherpy.10 In this regard, nanomaterials could be applied as active drug carriers
since their surface can be easily modified to be pH-responsive.13 The functional groups
on the nanomaterials can be protonated or deprotonated according to pH of the
environment and used to control the drug release.14 For example, the carboxylic acid
groups controlled the deformation of polymeric nanocapsules.15 In a basic medium, the
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carboxyl groups were deprotonated, and the electrostatic attraction between the drug
and the carrier limited the drug release. However, in an acidic medium, the carboxyl
groups were protonated so that charged molecules had less resistance to transport
through the nanocapsules, resulting in the drug release. The charge variation weakened
the interactions to the drugs, which directly regulated the loading and releasing behavior
of drugs, which implied one of the designations in pH-mediated drug delivery.16 Using
electrostatic interactions to initiate drug release has been considered as a major pathway
for developing pH-responsive active drug delivery system.17
In the development of nanomaterial-based pH-responsive drug delivery
systems, several types of nanovehicles have been used, including polymer
nanocarriers,18-19 dendrimers,20 lipids,21-22 gold nanocarriers,23 carbon nanotubes16, 19
and mesoporous silica nanocarriers.24

Drugs were attached on those nanomaterials25,

loaded into their pores, or encapsulated into vacant domains of nanocarriers.26 Among
them, mesoporous silica nanocarriers attracted considerable attention due to their
decent biocompatibility, easy surface modification, high drug loading efficiency, and
good drug release pattern.8,

27-28

Accordingly, mesoporous silica is an excellent

candidate for drug loading and releasing nanocarriers in cancer therapies.29-32
Furthermore, multi-modal therapeutic strategies have been promoted due to
the development of nanomaterials.33 By combining different therapeutic modalities,
such as photodynamic therapy (PDT), photothermal therapy (PTT), radiotherapy, and
immunotherapy, the synergistic effect was provided an impressive therapeutic
outcome.34-39 Photothermal therapy is an non-invasive, convenient and promising
physical treatment for tumor cells. Several synthesized and modified high-quality
photothermal agents have been studied.40-41 Graphene-based nanomaterials, especially
reduced graphene oxide, have been used for photothermal therapy due to their high
2

photothermal conversion efficiency.42-46 For example, reduced graphene oxide that was
coated with a temperature-responsive polymer layer has been successfully applied in a
controllable drug release system triggered by a near-infrared (NIR) irradiation.47
Besides, Liu’s group selected a polymer layer to wrap graphene oxide, forming a stable
and biocompatible photothermal agent.44 Inspired by these works, we designed a
bifunctional nanocarrier using mesoporous silica matched with reduced graphene oxide
(rGO@msilica) for cancer treatment.
In this work, the designed sandwich structure of rGO@msilica nanocarrier has
both chemo and photothermal therapeutic capacities. The inner layer of the reduced
graphene oxide served as a photothermal agent owing to its superior NIR absorption
and photo thermal conversion efficiency.43 In the outer layer, the mesoporous silica
acted as a drug container. A chemotherapeutic agent, doxorubicin (DOX), was loaded
into the mesoporous silica carrier and adsorbed onto the rGO via noncovalent
interactions at neutral pH environment. In the acidic environment, DOX was gradually
released from the nanocarrier to fulfill the chemotherapeutic function. Meanwhile,
rGO@msilica showed a strong PTT effect under a NIR irradiation, which generated
synergistic therapeutic efficiency for destroying cancer cells. The developed
bifunctional nanocarriers might be an effective pH-responsive drug carrier for cancer
therapy.

2. Experimental Section
2.1. Chemicals.
Graphene oxide aqueous solution (GO, 5.0 mg/mL) was purchased from ACS
Materials. The following chemicals were purchased from Sigma-Aldrich Inc. and used
3

as received without further purification. They were doxorubicin hydrochloride (DOX,
C27H29NO11·HCl, 98%), tetraethyl orthosilicate (TEOS, C8H20O4Si, 98%), sodium
hydroxide

(NaOH,

98%),

hexadecyltrimethylammonium

bromide

(CTAB,

CH3(CH2)15N(Br)-(CH3)3, 96%), dimethyl sulfoxide (DMSO, (CH3)2SO, 99.9%),
hydrazine hydrate (N2H4，50%-60%) and hydrochloric acid (HCl, 36.5%-38%), ethanol
(C2H5OH, 99.8%), 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT, C18H16BrN5S, 98%). The deionized (DI) water (18.2 MΩ∙cm) was obtained from
a Millipore water purification system. Dulbecco′s modified eagle′s medium (DMEM),
Leibovitz’s L-15 medium (L-15) and 4’-6-diamidino-2-phenylindole (DAPI, C6H15N5)
were purchased from ThermoFisher Scientific Inc. Colon cancer cell line (SW620) was
provided by MD Anderson Cancer Center. Lung cancer cell line (A549) was purchased
from the American Tissue Culture Collection (ATCC). Both cells were cultured in the
School of Medicine and Health Sciences in the University of North Dakota at 37 °C
with 5% CO2.
2.2. Instruments.
An Eppendorf 5804 centrifuge (Eppendorf, Hamburg, BRD) and an
ultrasonicator (Branson, Buffalo Grove, IL, USA) were used to separate and disperse
nanocarriers. The hydrodynamic diameters and surface potential of the nanocarriers
were characterized by the Zetasizer Nano ZS (Marlwen, Worcestershire, UK). A Hitachi
SU8010 field emission Scanning Electron Microscope (Hitachi, Tokyo, Japan) was
used to take the TEM image of rGO. A Hitachi 7500 Transmission Electron Microscope
(Hitachi, Tokyo, Japan) and JEOL JEM-2100 high-resolution transmission electron
Microscope (JEOL Ltd., Tokyo, Japan) were employed to image the structure of
mesoporous silica layer. The pore size and surface area of the nanocarriers were
measured by an autosorb-iQ gas sorption analyzer (Quantachrome Instruments,
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Boynton Beach, FL, USA). The absorption and fluorescence spectra were obtained by
a PerkinElmer Lambda 1050 UV/VIS/NIR spectrometer (PerkinElmer, Santa Clara, CA,
USA) and a Jobin Yvon Horiba Fluorolog-3 Spectrofluorometer (Horiba Scientific,
Edison, NJ, USA), respectively.

A BWF1 series fiber-coupled diode laser system (808

nm, B&W TEK Inc., Newark, DE, USA) was utilized to irradiate the nanocarrier for
executing photothermal therapy.

The temperature was monitored with a SK-1250MC

electronic thermometer (Sato Keiryoki, Tokyo, Japan). A Multiskan spectrum
spectrophotometer (ThermoFisher Scientific, Waltham, UK) was employed to perform
MTT test for measuring the optical density at 570 nm in dimethyl sulfoxide (DMSO)
solution.
2.3. Synthesis of the Reduced Graphene Oxide / Mesoporous Silica Nanocarrier
(rGO@msilica).
The rGO@msilica nanocarrier was prepared by the following steps. In the
beginning, 50.0 mL of deionized water was mixed with 1.0 mL of 5.0 mg/mL GO
aqueous solution, followed by 30 min of sonication. The solution was centrifuged at
7,000 rpm for 30 min to remove the precipitate. Afterwards, 500 mg of CTAB and 20
mg of sodium hydroxide were added into the previous solution, followed by sonication
for 3 h to build a basic condition for hydrolysis of TEOS. Then, an aliquot of 250 µL
of TEOS was added into the above solution and stirred for 7 h in a 40 °C water bath.
The obtained nanocarrier solution was refluxed in 50 mL HCl/EtOH solution (0.1%,
v/v) for 3 h to remove the excess CTAB, followed by washing with ethanol and water.
The precipitate was re-dispersed in 50 mL water. An aliquot of 80 μL of hydrazine
hydride was added and stirred at 100 °C overnight. The final rGO@msilica was washed
with water and ethanol (each for three times) and dried in an oven (80°C) for future
usage. The GO@msilica nanocarrier was prepared as a control group following the
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same procedure mentioned without the reduction process by hydrazine hydride.
2.4. Measurement of Pore Size and Surface Area.
The obtained dry rGO@msilica nanocarrier was loaded into a 12-mm sample
cell in the autosorb-iQ gas sorption analyzer. Before this loading, the weight of the
empty sample cell with glass and glass rod was measured. Then, the loaded cell was
put into a heating mantle for degassing at the temperature of 120 °C for 2 h. After
degassing, the sample was re-weighed. Then the loaded cell was transferred into the
analysis port. The isotherm curve (volume absorbed vs relative pressure) was plotted,
and the pore size and the surface area were obtained.
2.5. Measurement of Drug Loading and Releasing Efficiency.
An aliquot of 2.0 mL of 1.5 mg/mL rGO@msilica nanocarrier aqueous
solution was mixed with 24 μL of 5.0 mg/mL doxorubicin (DOX) and 2.0 mL of 20
mM PBS buffer (pH=7.4) at room temperature for 24 h. Drug loading efficiency was
calculated by measuring the fluorescence intensity of the original solution and the
supernatant after centrifugation (11,500 rpm, 15 min). Furthermore, the pH-dependent
drug release behavior of the nanocarrier was investigated under pH 7.4 and pH 5.0.
Briefly, two aliquots of 1.0 mL of 0.75 mg/mL of DOX-loaded rGO@msilica
nanocarriers were adjusted to two different pH values, pH 5.0 and pH 7.4, in a PBS
buffer. At different time interval, the solution was centrifuged at 11,500 rpm for 15 min.
Then, the supernatant was collected for fluorescence measurement, which was used to
calculate the amount of DOX with a prepared calibration curve. Similarly, the
photoresponsive release of DOX under a NIR irradiation was evaluated in different pH
solutions. The initial temperature was adjusted at 37 °C using a water bath. The cuvette
was exposed to a NIR diode laser (0.3 W/cm2) for 15 min and cultivated for different
period of intervals, including 1 h, 2 h, 3 h, 4 h, 5 h and 6 h.
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2.6. Photothermal Effect of rGO@msilica.
To evaluate photothermal effect of the GO@msilica nanocarrier and
rGO@msilica nanocarrier, the temperature of an aliquot of 2.0 mL of GO@msilica
nanocarrier (0.1 mg/mL) and rGO@msilica nanocarrier (0.1 mg/mL) under an NIR
laser (808 nm, 0.3 W/cm2) irradiation were recorded by an electronic thermometer.
2.7. Biocompatibility of rGO@msilica Nanocarrier.
A549 lung cancer cells (5.0×104 cells/well) were incubated in a DMEM cell
culture medium in a humidified atmosphere with 5% of CO2 at 37 °C for 24 h.50 The
cells were rinsed with a PBS buffer and then treated with different concentrations of
unloaded rGO@msilica nanocarriers (0, 2.5, 2.5×10-2, 2.5×10-3, 2.5×10-4, and 2.5×10-5
mg/mL) for 24 h in a DMEM medium. The cells were washed to remove the physically
adsorbed nanocarriers, then an MTT solution (5.0 mg/mL, 10 μL) was subsequently
added into each well for incubation of 4.0 h. After the medium was removed, DMSO
was added to dissolve the formed formazan violet crystals. The absorbance of formazan
in DMSO solution was detected by a microplate reader at 570 nm. A different cell line
(colorectal cancer cells SW620)51 has been used to validate the biocompatibility as well.
2.8. Chemotherapeutic Effect of the DOX-loaded rGO@msilica Nanocarrier.
A549 lung cancer cells (5.0×104 cells/well) were incubated in DMEM cell
culture medium in a humidified atmosphere with 5% of CO2 at 37 °C for 24 h. Then,
the cells were treated with different concentrations (0, 2.5×10-5, 2.5×10-4, 2.5×10-3,
2.5×10-2, 2.5×10-1, and 2.5 mg/mL) of DOX-loaded rGO@msilica nanocarriers for 12
h in a DMEM medium. An MTT assay was performed to measure the cell viability after
the treatment. Furthermore, the impact of incubation time on the cell viability was
investigated by MTT assay. Briefly, A549 cells were cultured with DOX loaded
rGO@msilica nanocarriers (25 μg/mL) for various time periods (0 h, 3 h, 12 h, 24 h,
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30 h, 36 h, and 42 h), followed by the MTT assay to assess the cell viabilities.
2.9. Confocal Fluorescence Imaging of Drug Release in Cancer Cells.
A549 cells (2.0×105 cells/well) were incubated in the cell culture medium in a
humidified atmosphere with 5% of CO2 at 37 °C for 24 h in a 24-well cell culture plate.
Afterwards, an aliquot of 500 µL of DOX-loaded rGO@msilica nanocarrier dispersed
in the culture medium (25 μg/mL) was added into the above cell culture plates. The
cells were incubated at 37 °C for 10 min, 6 h and 24 h, respectively. Cell nuclei were
stained by 300 nM DAPI solution. After washing the cells with PBS buffer to remove
the excess DAPI and DOX-loaded rGO@msilica nanocarrier, the fluorescence imaging
was taken with a confocal fluorescence microscope.
2.10. Synergistic Therapeutic Efficiency.
The synergistic therapeutic efficiency of DOX-loaded rGO@msilica
nanocarrier was evaluated using A549 cells and SW620 cells. First, the A549 cells (5.0×
104 cells/well) were seeded on a 96-well plate and cultured for 24 h. Five different
treatment groups, including the control group, pure rGO@msilica (25 μg/mL), DOXloaded rGO@msilica (25 μg/mL), rGO@msilica (25 μg/mL) with irradiation, and
DOX-loaded rGO@msilica (25 μg/mL) with and irradiation, were used to assess the
synergistic therapeutic efficiency. For the irradiation, an 808 nm laser with a power
density of 0.3 W/cm2 was used for 15 min. After the treatments, the cells were incubated
for another 6 h or 24 h, followed by the measurement of cell viability using MTT assay.
The therapeutic effect was also validated in SW620 cells using the same protocol.
3. Results and Discussion
3.1. Design and Synthesis of the DOX-Loaded rGO@msilica Nanocarrier.
The design of the bifunctional DOX-Loaded rGO@msilica nanocarrier was
illustrated in Scheme 1. Although multifunctional drug delivery systems have been
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developed by many research groups, the DOX-loaded rGO@msilica nanocarrier
developed in this work have the following three main features. First of all, the usage of
rGO not only provides a powerful photothermal agent to ablate cancer cells with the
irradiation of NIR laser, but also works as the controllable drug carrier for DOX.44 The
large sp2 carbon clusters in rGO efficiently load hydrophobic drugs, like DOX, through
π−π stacking under the normal environment.48-49 However, when the environment
becomes acidic, the amine groups and carboxyl groups on rGO are protonated, resulting
the strong repulsive force between the positive charged DOX and rGO.50-51 This
enhanced repulsive force will trigger the drug release from the nanocarrier. Moreover,
under the NIR laser irradiation, the acidic triggered drug releasing efficiency was
accelerated by the elevated temperature. Second, the mesoporous silica layers have
three important functions in this design. With the protection of the mesoporous silica
layers, rGO become more stable than the pure rGO without any modification. Also, the
excellent biocompatibility of silica ensures the low cytotoxicity of the nanocarrier for
drug delivery. More importantly, the mesopores in the silica layer provide an ideal
container for drugs, which could be easily triggered to release in the acidic
environment.52-54 Third, the synergistic effect by the two cancer killing mechanisms,
including photothermal ablation and acidic triggered chemotherapy greatly enhanced
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the therapeutic efficiency for cancer treatment.

Scheme1. Schematic illustration of the DOX-loaded rGO@msilica nanocarrier as a
multifunctional drug delivery system for synergetic chemo-photothermal therapy of
cancer.
To prepare the nanocarrier, mesoporous silica was firstly coated on the surface
of a single layer GO (Scheme 1 A) by the hydrolysis of TEOS with assistance of CTAB
in an alkaline environment, forming a sandwich structure (Scheme 1B). Then, the inner
GO was reduced by hydrazine hydride to form the reduced graphene oxide (rGO,
Scheme 1 C). Thereafter, a chemotherapeutic drug, doxorubicin hydrochloride
(DOX),55-58 was loaded into the pores of mesoporous silica layer and the surface of rGO
(Scheme 1 D) through electrostatic interaction and - stacking. Triggered by the acidic
tumor microenvironment, DOX would be released for chemotherapy, which would also
be enhanced by the photothermal effect under a NIR laser irradiation (Scheme 1 D).
3.2. Characterization of the DOX-Loaded rGO@msilica Nanocarrier.
The morphology and size of rGO@msilica nanocarrier was characterized with
a regular transmission electron microscope (TEM) and a high-resolution transmission
electron microscope (HRTEM). Without mesoporous silica coating, the pure rGO
surface was smooth and no pores structure was observed (Figure 1A). After the
formation of the rGO@msilica sandwich structure, the TEM image (Figure 1B) clearly
10

demonstrated the existence of mesopores silica with the lateral size around 300-500 nm.
The HRTEM image (Figure 1C) showed the average pore size of mesoporous silica was
about 3 nm.

A

B

C

Figure 1. TEM images of rGO@msilica nanocarrier. (A) A pure rGO sheet. (B) low
magnification TEM image of rGO@msilica nanocarrier (300 - 500 nm). (C) HRTEM
image of rGO@msilica nanocarrier.
Furthermore, the composition of the synthesized rGO@msilica nanocarriers
was investigated using energy-dispersive X-ray spectroscopy (EDS) equipped on a
SEM. The elemental mapping from EDS showed the overlapping images of elements
of C, Si, and O as designed (Figure 2). However, due to the low content of N in the
rGO@msilica, no element N map was obtained.
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A

B

C

D

Figure 2. Elemental analysis of the of rGO@msilica nanocarriers. STEM image of
the rGO@msilica nanocarrier (A) and its corresponding elemental maps of Si (B, green
color), carbon (C, yellow color), and oxygen (D, red color) (scale bar = 250 nm).
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Figure 3. Nitrogen adsorption-desorption isotherm curve (A) and the pore size
distribution (B) of rGO@msilica nanocarriers based on BJH method. The outgas was
conducted at 120 °C for 1.2 h. (C) Absorption spectra of GO, GO@msilica and
rGO@msilica nanocarrier. (D) Zeta potential of GO, GO@msilica and rGO@msilica
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nanocarrier in pH 5.0, 10 mM PBS buffer at room temperature.
The surface area and pore sizes of the rGO@msilica were further measured
using a surface area analyzer. The results of N2 adsorption-desorption isotherm (Figure
3A) and the pore size distribution curve (Figure 3B) indicated that the rGO@msilica
nanocarrier possessed a large BET surface area (770 m2/g). A computational
mechanical modeling method, BJH method (Barrett, Joyner, and Halenda), was
employed for calculating the pore size distribution from the experimental isotherms
using the Kelvin model of pore filling. The pore volume was 1.21 cm2/g and the average
pore size was estimated as 3.1 nm, which was consistent with the result from the
HRTEM images.
To further confirm the formation of the rGO@msilica nanocarrier, we also
monitored the absorption spectra (Figure 3C) during the synthetic process. The
absorption peaks of GO and GO@msilica nanocarrier were both at 230 nm, which was
the characteristic peak of GO. After reduction, the peak was shifted to 260 nm,
indicating the formation of rGO. Meanwhile, the absorbance in the NIR range was
significantly enhanced when GO was reduced to rGO, which was useful for PTT using
NIR laser. Moreover, zeta potentials of GO, GO@msilica and rGO@msilica
nanocarrier were measured, which were −39.6  0.5 mV, −30.3  2.1 mV, and −16.8 
1.3 mV, respectively (Figure 3D). By coating GO with mesoporous silica, the zeta
potential decreased, but kept relatively large negative charge due to the formation of
the -OH groups on silica surface. With the formation of rGO, the surface oxygencontaining groups of GO were partially removed, resulting in the further decrease of
the zeta potential. Overall, the negative charge surface of rGO@msilica nanocarrier
ensured the good stability of the nanocarrier in buffer and medium for bioapplications.
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3.3 Drug Loading.

Figure 4. DOX loading into rGO@msilica nanocarrier. (A) The fluorescence spectra of
DOX (0.01 mg/mL) at different pH values. (B) Calibration curve of DOX in 10 mM
pH 7.4 PBS buffer (DOX concentration: 3.0×10-2, 2.0×10-2, 1.0×10-2, 5.0×10-3, 2.5×103
, 1.3×10-3 mg/mL). (C) Fluorescence spectra of initial pure DOX solution to be used
for loading (curve a) and the supernatant after centrifuging DOX-loaded rGO@msilica
nanocarrier (curve b). Inset shows the initial pure DOX solution (a) and the DOXloaded rGO@msilica nanocarrier solution after centrifugation (b). (D) The fluorescence
spectra of (a) pure DOX (3.0×10-2 mg/mL), (b) 7.5×10-1 mg/mL DOX-loaded
rGO@msilica nanocarriers (with equivalent DOX concentration of 2.7×10-2 g/mL) in
10 mM pH 7.4 PBS buffer (c) and pure 10 mM pH 7.4 PBS buffer solution as control.
Excitation wavelength: 480 nm, Emission wavelength: 591 nm.
One of the most important criteria for a successful stimuli-responsive drug
delivery platform is that the loaded drug should be released only under the desired
conditions with minimal nonspecific leakage. Due to the strong fluorescence of DOX,
we used the fluorescence intensity of DOX to measure the loading efficiency and
monitor the drug releasing behavior. To avoid false signals caused by the fluorescence
variation of DOX, we first studied the pH effect on the fluorescence intensity of the
pure DOX molecules. The results showed that DOX was insensitive to pH in the range
14

of 2 to 9 (Figure 4A).
The pH insensitive feature of DOX ensured the accuracy of the measurement
of DOX by fluorescence intensity in this work. Therefore, a calibration curve based on
the concentration of DOX and fluorescence intensity was established to quantify DOX
in different environment (Figure 4B). To calculate the drug loading efficiency, a certain
amount of DOX was loaded to the rGO@msilica nanocarrier as described in the
experimental section. The drug loading efficiency was measured by the detection of the
fluorescence intensities of the initial pure DOX solution (Figure 4C, curve a) and the
supernatant after centrifuging the DOX-loaded rGO@msilica nanocarrier (Figure 4C,
curve b). The loading efficiency was calculated to be 90% and the loading amount was
36.0 mg DOX/g nanocarrier. Interestingly, after loading DOX into rGO@msilica
nanocarrier, the fluorescence of DOX was strongly quenched by rGO due to its
universal fluorescence quenching ability, indicating the successful drug loading. As
shown in Figure 4D, the fluorescence intensity of DOX-loaded rGO@msilica was only
1% of the original pure DOX solution.
3.4. pH-Responsive Drug Release.
Upon the successful loading of DOX into the rGO@msilica nanocarrier, the
feature of the pH-triggered drug release behavior was investigated. Two pH values,
including pH 7.4 and pH 5.0, were selected for the investigation. By monitoring the
fluorescence intensity changes of the supernatant of the DOX-loaded rGO@msilica
nanocarriers after centrifugation, the amount of released DOX was measured. As shown
in Figure 5A, only 4.8% of the loaded DOX was released in the PBS buffer with pH
7.4 without NIR laser irradiation in the first 6 hours. In contrast, a significantly large
amount of DOX (38.0 %) was released from the DOX-loaded rGO@msilica
nanocarrier when the pH was changed to 5.0, indicating the accelerated drug releasing
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profile triggered by the acidic environment.
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Figure 5. (A) Cumulative release of DOX from DOX-loaded rGO@msilica (1.0 mg/mL)
within different pH buffers with or without irradiation. An NIR laser (808 nm, 0.3
W/cm2) was used for irradiation. (B) Temperature increasing curves of PBS,
GO@msilica nanocarrier (0.5 mg/mL) and rGO@msilica nanocarrier (0.5 mg/mL)
solutions exposed to an NIR laser (808 nm, 0.3 W/cm2) for 15 min. The solution volume
was 2.0 mL.
Due to the enhanced NIR absorbance of rGO@msilica nanocarrier and the
reported PTT effect of rGO, we also investigated the temperature change of the
rGO@msilica nanocarrier under the 808 nm laser irradiation. The temperature of the
rGO@msilica nanocarrier solution was monitored under the irradiation of an 808 nm
laser (0.3 W/cm2) for 15 min (Figure 5B). Without the nanocarrier, the temperature of
the PBS increased less than 0.5°C under the same irradiation (Figure 5B). In contrast,
the temperature changes of GO@msilica nanocarrier solution (0.5 mg/mL) only
elevated 4 °C (Figure 5B). Significantly, the temperature changes of the rGO@msilica
nanocarrier solution (0.5 mg/mL) exceeded 14 °C (Figure 5B) with the irradiation.
Therefore, the inner layer rGO of the nanocarrier contributed to the higher photothermal
effect, which was also consistent with the enhanced absorption in the NIR range of rGO
(Figure 3C). Considering that the normal human body temperature is about 37°C, the
final temperature caused by rGO@msilica with irradiation could be over 51°C, which
would be high enough to kill most of the malignant cells.
More importantly, we proposed that the acid-triggered drug releasing rate
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would be increased attributing to the enhanced diffusion speed at a higher temperature.
Therefore, the drug-releasing profile of DOX-loaded rGO@msilica nanocarrier was
also investigated under the laser irradiation in different pH solutions. We first tested
irradiation-triggered DOX releasing profile of DOX-loaded rGO@msilica nanocarrier
in pH 7.4 solution. As shown in Figure 5A, 9.1 % of the loaded DOX was released in
the first 6 hours with NIR irradiation. Compared to the one without NIR irradiation, an
additional of 4.2% drug release was obtained. When the acidic pH of 5.0 was utilized
with the NIR irradiation to trigger the drug release, 48.3 % of DOX was released from
the nanocarrier in 6 hours (Figure 5A), which was significantly higher than the single
trigger of acidic pH or NIR laser irradiation. Therefore, with the highly efficient
photothermal effect, rGO@msilica nanocarrier was expected not only to work as a
photothermal agent to directly kill cancer cells, but also to possess higher drug release
rate with the elevated temperature under the NIR irradiation.
3.5 Biocompatibility of the rGO@msilica Nanocarriers.
The biocompatibility of the nanocarrier was investigated before the application
of the nanocarrier for drug delivery. Two cancer cell lines, including human lung cancer
cell line (A549) and human colorectal carcinoma cell line (SW620), were selected for
this study because of their widespread prevalence and high mortality. As described in
the experimental section, the cells were incubated with different concentrations of
rGO@msilica nanocarrier without loading DOX. After 24 hours of incubation, an MTT
assay was performed to evaluate the cell viability of these two cell lines. As shown in
Figure 6, the cell showed high viability of 84.7% even at the concentration of 2.5
mg/mL. There was no significant difference between different treatment groups (* p <
0.05), indicating the excellent biocompatibility of the rGO@msilica nanocarrier.
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Figure 6. Cell viability of A549 cells (A) and SW620 cells (B) after the treatments with
various concentrations of rGO@msilica nanocarriers for 24 h.
3.6. Chemotherapy Evaluation of the DOX-Loaded rGO@msilica Nanocarrier.
Due to the excellent biocompatibility of the rGO@msilica nanocarrier, the
chemotherapy of the DOX-loaded rGO@msilica nanocarrier was investigated in vitro.
A549 lung cancer cells were incubated with different concentrations of DOX-Loaded
rGO@msilica (2.5×10-5 to 2.5 mg/mL) for 12 hours, followed by the MTT assay to
evaluate the cell viability. As shown in Figure 7A, when the concentration of the DOXLoaded rGO@msilica increased, the cell viability decreased significantly. 80.4% of the
cancer cells were killed when the concentration of DOX-loaded rGO@msilica
nanocarrier reached 2.5 mg/mL. The results demonstrated a dose-dependent therapeutic
effect of the DOX-loaded rGO@msilica nanocarrier to the A549 cancer cells. The IC50
concentration was calculated to be 2.5×10-2 mg/mL at the period of 12-hour incubation.
The effect of the incubation period on the A549 cell viability was also investigated at
the concentration of 2.5×10-2 mg/ mL . As shown in Figure 7B, the A549 cell viability
decreased as the time collapsed and reached the plateau at 30 hours. At this moment,
82.9% of cancer cells were killed and remained the same value as the time increased to
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40 hours. The result indicated that the drug release from the rGO@msilica nanocarrier
was a slow and effective process.
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Figure 7. (A) The cell viability of the A549 cells with different concentrations of
DOX-loaded rGO@msilica nanocarrier. The concentration of DOX loaded
rGO@msilica was from 2.5×10-5 mg/mL to 2.5 mg/mL. The incubation time was 12
hours. (B) The time effect of the DOX-loaded rGO@msilica nanocarrier on the cell
viability of the A549 cells. The concentration of the DOX-loaded rGO@msilica
nanocarrier was 2.5×10-2 mg/mL.
3.7. Cellular Uptake and Drug Release in Cells.
To further confirm the drug release behavior of the nanocarrier in cancer cells,
confocal fluorescence images of A549 cells were taken under different incubation time
periods with the DOX-loaded rGO@msilica nanocarrier (Figure 8A). The cells were
also stained with DAPI23 as it could bind with DNA to show strong blue fluorescence.
When the DOX-loaded rGO@msilica nanocarrier (2.5×10-2 mg/mL) was incubated
with cells for only 10 min, the fluorescence signal from DOX was mainly localized
around the nucleus (Figure 8A), which was because the un-released DOX from the
nanocarrier couldn’t enter the nucleus with the relative large size of the nanocarrier.
However, when the incubation time increased to 6 hours, most of the DOX fluorescence
was co-localized with DAPI in the nucleus (Figure 8A), indicating the effective drug
release from the nanocarrier. When the incubation time increased to 24 hours, the red
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fluorescence spread in both nucleus and cytoplasm due to the drug release from the
nanocarrier. The intensities of these fluorescence signals were quantitatively measured
(Figure 8B). The red fluorescence from DOX was gradually enhanced in cells with time,
indicating the gradually drug release in cells.
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Figure 8. (A) Confocal fluorescence images of A549 cells incubated with DOX-loaded
rGQ@msilica nanocarrier at different time periods, including 10 min, 6 h, and 24 h.
The nucleus was counterstained with DAPI (blue). The red fluorescence was from DOX.
(B) The fluorescence intensity of DOX in cells was quantified by Image J software.
(**** p < 0.0001)
3.8. Synergistic Chemo-Photothermal Therapy of Cancer Cells.
As previously discussed, rGO was well recognized as an efficient
photothermal agent for cancer treatment.36 Combined with the chemotherapy of the
loaded DOX, the synergistic chemo-photothermal therapeutic effect of the DOX-loaded
rGO@msilica nanocarrier was investigated under an NIR irradiation (808 nm, 0.3
W/cm2). As shown in Figure 10, SW620 cells (Figure 9A) and A549 cells (Figure 9B)
were incubated with 2.5×10-2 mg/mL DOX-loaded rGO@msilica nanocarrier for 6
hours and 24 hours, followed by the NIR laser irradiation (808 nm, 0.3 W/cm2) for 15
min. Then, the cells were cultured in medium for additional 12 h, followed by the MTT
assay to assess the cell viabilities. The results showed that pure rGO@msilica
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nanocarrier has no significant cytotoxic activity to both cell lines compared with the
control group, indicating the great biocompatibility of the rGO@msilica nanocarrier.
Taking SW620 cells as an example, the photothermal therapy effect caused by the
combination of the rGO@msilica nanocarrier and NIR laser irradiation showed a
moderate therapeutic effect, resulting in the reduction of cell viability to 60% and 66 %
at 6 hours and 24 hours, respectively. Moreover, the cell viability of SW620 cells treated
with DOX-loaded rGO@msilica nanocarrier without NIR irradiation caused severe cell
death, resulting in the cell viabilities of 51% and 19% at 6 hours and 24 hours,
respectively. More importantly, the combination of the chemo-photothermal therapy by
treating cells with DOX-loaded rGO@msilica nanocarrier and NIR irradiation killed
more cells. At 6 hours and 24 hours, the cell viabilities decreased to 31% and 9%,
respectively. Similarly, the synergistic therapeutic efficiency was demonstrated in the
treatment of A549 cells (Figure 9B). Thus, DOX-loaded rGO@msilica nanocarrier
composed of chemo-photothermal therapeutic capacities demonstrates better
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Figure 9. The cell viabilities of SW620 (A) and A549 (B) cells after different treatments.
“-” stands for no treatment. “+” stands for the treatment. The cells were incubated with
nanocarriers for 6 h and 24 h, respectively, followed by the 808 nm laser irradiation of
15 min. (**** p < 0.0001)

21

4.

Conclusions

In summary, we have designed and constructed a bifunctional DOX-loaded
rGO@msilica nanocarrier with photothermal effect and pH-responsive drug release
properties. The large surface area and pore size of the rGO@msilica nanocarrier
possessed effectively drug loading efficiency and pH-responsive drug releasing
behavior. Moreover, in the acidic environment with NIR irradiation, the drug releasing
efficiency was significantly enhanced, causing significant cancer cell death. The
synergetic effect of chemotherapy and photothermal therapy under NIR irradiation
demonstrated the enhanced cancer cell killing efficacy in vitro. The developed
rGO@msilica nanocarriers might have great potential for fighting cancer by the
combined therapeutic strategies.
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CHAPTER II
GRAPHENE OXIDE-BASED FLUORESCENCE ASSAY FOR SENSITIVE
DETECTION OF DNA EXONUCLEASE ENZYMATIC ACTIVITY
1. Introduction
In enzymatic studies, exonuclease families have been involved in numerous
aspects of cellular metabolism and maintenance in physiological processes, such as
assisting DNA proofreading and maintaining genome stability.59 3´-5´ exonuclease III
(Exo III), isolated from E. coli in 1964, was a key bifunctional enzyme and essential to
genome stability. The function of Exo III was to remove mononucleotides from 3´hydroxyl termini of double-stranded DNA.60 In the process of DNA replication, 3´-5´
exonuclease possesses indispensable functions, such as repairing DNA breaks,61
assuring the accuracy of replication process and stabilizing the mutation rates in cells.6265

The defects of 3´-5´ exonuclease enzymes render cells processing wrong transcription,

translation and eventually lacking protection from cancer development, in particular
under long periods of stress.59,

66

Therefore, it is highly desired to develop well-

performed analytical methods for the precise measurement of the 3´-5´ exonuclease
activity.67-68
Traditional methods for the detection of 3´-5´ exonuclease enzymatic activity
are based on gel electrophoresis, which requires radioactive-labelled DNA probes.
However, the liabilities of these methods include time-consuming measurements,
tedious steps and safety concerns because of radiographic exposure process.69-71 In
order to overcome these limitations, a number of fluorescent biosensing systems have
been developed due to their simple and cost-effective properties.72-74 For example,
Yang et al. designed a label-free, “turn-on” fluorescence assay for the rapid detection
of exonuclease III activity based on the Tb3+-promoted G-quadruplex.75 Zhang´s group
developed a triple-color fluorescent probe by lab-on-a-DNA-molecule for simultaneous
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detection of multiple exonucleases.76 Recently, we constructed a dual molecular hairpin
system to distinguish various exonucleases rapidly.77 Comparing these approaches with
traditional methods, both the cost and complexity have been significantly reduced.
However, the relatively high background signals and limit of detection constrain the
detection of exonuclease activity at low concentration in complex matrix.
Graphene oxide (GO), as a universal fluorescence quencher, is a twodimensional oxidized version of graphite.78-79 It comprises of carbon−carbon sp2
domains together with multiple functional groups, such as carboxylic group, hydroxyl
and epoxide groups.80 One of the most interesting roles of GO in sensing systems was
to serve as a universal fluorescence quencher through fluorescence resonance energy
transfer (FRET).81 For example, fluorophore-labeled single strand DNA (ssDNA)
molecules can be easily attached onto the surface of GO by the strong π-π stacking
interactions between GO and exposed nucleobases, inducing significant fluorescence
quenching.82-87 In contrast, the binding force would become much weaker once the
double-stranded DNA (dsDNA) was formed, which releases the fluorophore from the
GO and restores the fluorescence. The difference of the binding forces between GO to
ssDNA and dsDNA has been widely used to construct assays for detecting DNA,
proteins, enzymes, metal ions, etc.88 For instance, Min et al.72 used this strategy to
construct a fluorescent sensor for detecting the activity of Exo III, in which the
fluorescence was significantly decreased in the presence of Exo III. However, the signal
“turn-off” strategy might have high background noise to affect the sensitivity, which
hampered its wide applications.
In this work, we have developed a “turn-on” fluorescence assay for monitoring
of 3′-5′exonuclease enzymatic activity based on the interaction between GO and a
DNA hairpin probe (HP). The developed assay showed an ultra-low limit of detection
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of 0.001 U/mL in buffer in 0.004 U/mL in 25-times diluted serum sample. This highly
sensitive and selective assay provided a promising new technology for monitoring of
3´-5´ exonuclease enzymatic activity in clinical diagnosis.
2. Experimental Section
2.1. Chemicals and Instruments.
Graphene oxide aqueous solution (5 mg/mL) was purchased from ACS
Material (Pasadena, CA). The sequence of the hairpin probe (HP) was
5´-TTTTTTTTTTGGATCCCGCTTCTTTTTTTTTTGAAGCGGGATCCFAM-3´, which was synthesized by Integrated DNA Technologies (IDT). Exonuclease
III (Exo III), T4 polynucleotide kinase (T4 PNK), alkaline phosphatase, calf Intestinal
(CIP), uracil-DNA glycosylase (UDG), exonuclease I (Exo I), RecJf, lambda
exonuclease (Lambda Exo) and 10x NEBuffer 2 were obtained from New England
Biolabs (NEB). PBS tablets, ethylenediaminetetraacetic acid and fetal bovine serum
were purchased from Sigma Aldrich Inc. The deionized (DI) water (18.2 MΩ • cm) was
produced from a Millipore water purification system. Fluorescence measurements were
performed on a RF-6000 fluorophotometer (SHIMADZU, Kyoto, Japan). The
excitation wavelength was set to be 480 nm and the emission was recorded from 500
nm to 650 nm. The fluorescence intensity at 517 nm was selected to evaluate the
performance of Exo III detection. Both the widths of excitation and emission slits were
10.0 nm. All the experiments were carried out at 37 oC. The morphology and element
analysis of GO were carried out on a Hitachi SU8010 field emission Scanning Electron
Microscope (SEM) equipped with an Energy-dispersive X-ray spectrometer.
2.2. Feasibility of the sensor for Exo III detection
A 100 µL aliquot of 1X NEBuffer 2 containing 100 nM hairpin probe (HP)
was mixed with 1 µL of 50.0 U/mL Exo III and then incubated at 37 oC for 10 min.
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Then, 1 µL of 2.0 mg/mL GO solution was added and incubated at 37 oC for another 10
min. The fluorescence spectra of the solution were recorded with the excitation
wavelength of 480 nm.
2.3. Detection of Exo III activity
Briefly, a 100 µL aliquot of 1X NEBuffer 2 containing 100 nM hairpin probe
(HP) was mixed with 1 µL of various concentrations of Exo III and then incubated at
37 oC for 10 min. Then, 1 µL of 2.0 mg/ mL GO was added to the above solution and
incubated at 37 oC for another 10 min. The fluorescence intensity of the final solution
was detected with the excitation wavelength of 480 nm.
2.4. Evaluation of the selectivity
The selectivity of the assays was evaluated by testing the fluorescence signal
of the sensing system to other DNA digesting enzymes. Typically, a whole volume of
100 µL solution including HP (100 nM) and 10.0 U/mL of one of the following enzymes,
including Exo III, Exo I, Lambda Exo, RecJf, T4 PNK, CIP and UDG, were incubated
in a 37 oC water bath for 10 min. Then, 1 µL of 2.0 mg/ mL GO was mixed with the
above solution and incubated at 37 oC for additional 10 min. The fluorescence intensity
was measured with the excitation wavelength of 480 nm.
2.5. Exonuclease inhibition assay
To perform the inhibition assay on the activity of Exo III, a 100 µL aliquot of
solution containing 10.0 U/mL Exo III, 100 nM HP and various concentrations of EDTA
were incubated at 37 oC for 10 min, followed by addition of 1 µL of 2.0 mg/ mL GO
and incubated for another 10 min in a 37 oC water bath. The fluorescence intensity of
the final solution was recorded with the excitation wavelength of 480 nm.
2.6. Performance in 25-times diluted serum
A 0.4 mL volume of fetal bovine serum sample was added into 0.6 mL of
26

acetonitrile. The mixture was stirred at a vigorous vortex for 5.0 min, and then
centrifuged at 10,000 rpm for 10 min. The collected supernatant was diluted by 5 times
with 1X NEBuffer 2. To test the Exo III activity, a 100 µL aliquot of above 5-times
diluted FBS sample was first mixed with 100 µL of 200 nM HP, followed by adding
different concentrations of Exo III (0, 0.01, 0.05, 0.10, 0.15, 0.5, 1.0, 5.0 U/mL). The
above solution was then incubated in a 37 oC water bath for 10 min. Finally, a 2 µL of
2.0 mg/mL GO was added into the previous solution and incubated for another 10 min
in a 37 oC water bath. The fluorescence spectra were recorded with the excitation
wavelength of 480 nm.
2.7. Kinetic Analysis
In general, a 100 µL aliquot of 1X NEBuffer 2 containing 100 nM hairpin probe
(HP) was mixed with 1 µL of 2.0 mg/ mL GO. The fluorescence at 517 nm with
excitation at 480 nm was recorded with time. After the fluorescence was stabilized, 1
µL of various concentrations of Exo III was added and incubated at 37 oC. The
fluorescence intensity was monitored vs time for another 5 min.
3. Results and Discussion
3.1. Design of the Exo III assay
As shown in Scheme 2, a hairpin probe (HP) modified with a fluorophore
(FAM) at the blunt 3´-termini was used for this sensor. The intact FAM-tipped HP
without treatment of Exo III would be strongly absorbed onto GO due to the strong ππ stacking interaction between them, leading to absolute fluorescence quench through
the efficient FRET (Pathway a). However, the presence of Exo III digested phosphorester bonds and removed mononucleotides starting from the blunt 3´-termini of HP to
the whole double strand domain, generating a long unlabeled ssDNA and a FAMlabeled mononucleotide. With the addition of GO, the ssDNA was absorbed onto GO
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spontaneously but the affinity between the FAM-labeled mononucleotide and GO was
much weaker than that with ssDNA.89 Because of the dissociation between the GO and
FAM-labeled mononucleotides (Pathway b), fluorescence was significantly restored
compared with the sample without Exo III treatment.
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Scheme 2 Schematic illustration of the Exo III detection based on the GO and FAMlabelled HP.
3.2. Characterization of GO.
To In this sensor, we utilized GO as a quencher for its excellent quenching
efficiency to various fluorophores and its different affinities to ssDNA and
mononucleotide.78 To characterize the morphology of the GO and elemental analysis, a
SEM image of GO and corresponding Energy-dispersive X-ray spectroscopy mapping
were obtained (Figure 10). The average size of the GO sheets was around 800 nm,
which provided large surface area for ssDNA (loop domain) to attach to (Figure 10A).
The EDS analysis showed that GO mostly contained elements of carbon and oxygen
(Figure 10B-C). Moreover, the absorption spectrum of GO showed the typical peak at
230 nm of GO and broad absorption from UV to visible range (Figure 10E), making
GO an ideal fluorescent quencher for a variety of fluorophores.
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Figure 10. (A) The SEM image and corresponding elemental maps of GO in (B) carbon
(pink), (C) oxygen (yellow). (D) overlayered mapping of GO (scale bar = 10 µm). (E)
UV-vis absorption spectrum of GO with a typical absorption maximum at 230 nm.
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3.3. Feasibility investigation.
To demonstrate the feasibility of the developed sensor, the fluorescence
emission spectra of the HP under different conditions was recorded. As shown in Figure
11, pure HP (100 nM) emitted fluorescence at 517 nm with the excitation of 480 nm
(curve a). When GO was added with the HP, the fluorescence intensity was decreased
by over 95% (curve b) quickly, indicating the outstanding fluorescence quenching
ability of GO. In contrast, when HP was treated with Exo III before the addition of GO,
a relative high fluorescence intensity was collected (curve c), which was attributed to
the removal of the FAM-labelled blunt 3´-terminal part of HP by Exo III, increasing the
distance and weakening the FRET between GO and FAM. The variation of three spectra
confirmed that this sensing system could be applied for the detection of Exo III activity.

Figure 11. Fluorescence spectra of HP (100 nM) under different conditions. (a) 100 nM
HP, (b) 100 nM HP + 20 µg/mL GO, (c) 100 nM HP + 0.5 U/ mL Exo III + 20 µg/mL
GO. λex = 480 nm, All the reagents were incubated in 1X NEBuffer 2. λem = 500 nm 650 nm.
3.4. Optimization of experimental conditions.
To determine the optimal conditions for Exo III activity analysis, the impacts
of the concentration of GO, the concentration of HP, and the reaction time on the
sensing performance were investigated. As shown in Figure 12A, a time-based
fluorescence collection was performed with a whole volume of 100 µL solution
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(containing 20 μg/mL GO and 50 nM HP in 1X NEBuffer2) at 37 oC for 1200 s. After
the addition of GO, the fluorescence intensity decreased substantially in the first 100 s,
and then reached the plateau after about 200 s. Therefore, the reaction time in the
quenching process was set to 10 min.
Additionally, the concentration of GO needs to be considered to reach a low
background. The fluorescence intensity of HP with and without different concentrations
of GO were measured to assess the optimal concentration of GO. As shown in Figure
12B, F0 refers to the fluorescence intensity of 100 nM HP without GO, and F refers to
the fluorescence intensity of 100 nM HP after the addition of various concentrations of
GO. The ratio of F/F0 was decreased as the concentration of GO elevated, indicating
the concentration-dependent quenching ability of GO. The ratio reached to a plateau
after the concentration enhanced to 20 µg/mL. Therefore, in the following experiments,
we used 20 µg/mL as the optimal concentration of GO to perform the subsequent
detection.
A

B
Adding GO

Figure 12. (A) A time-based fluorescence intensity curve was collected in 100 μL 1X
NEBuffer2 solution containing 50 nM HP solution with addition of 20 μg/mL GO at 37
o
C for 1200 s. (B) Fluorescence intensity ratios of F/F0 at different concentrations of
GO. F0 refers to the fluorescence intensity of 100 nM HP without GO, and F refers to
the fluorescence intensity of 100 nM HP after the addition of various concentrations of
GO. λex = 480 nm, λem = 517 nm.
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The concentration of HP was the third impact that needs to be optimized. A
series of concentrations of HP were incubated with 50.0 U/mL Exo III, followed by
mixing with 20 µg/mL GO (Figure 13). Fluorescence intensity of the above solution
was recorded and designated as F. In contrast, another series of same concentrations of
HP were directly mixed with 20 µg/mL GO only, whose fluorescence intensity was
defined as F0. The corresponding ratios of F to F0 reached maximum value at the
concentration of 100 nM of HP, suggesting the highest sensitivity at this concentration.
Consequently, we set the concentration HP to 100 nM for the following experiments.

Concentration of HP (nM)

Figure 13. The effect of concentration of HP on the performance of the sensor. F
referred to the fluorescence intensity of different concentrations of HP treated with 50.0
U/mL of Exo III followed by the addition of 20 µg/mL GO. F0 represented the
fluorescence intensity of the same series of HP without treatment of Exo III in the
presence of 20 µg/mL GO. λex = 480 nm, λem = 517 nm.
3.5. Exo III detection.
To investigate the sensitivity of the sensor towards Exo III, 100 nM HP
solution was treated with different concentrations of Exo III for 10 min at 37 oC,
followed by the addition of 20 µg/mL GO. As shown in Figure 5A, the fluorescence
intensity of FAM increased when the concentration of Exo III increased from 0 U/mL
to 20.0 U/mL. The results showed that the dynamic range was from 0 U/mL to 20.0
U/mL (Figure 14B), with a linear range between 0.01 U/mL to 0.5 U/mL (the inset of
32

Figure 14B). The calibration curve showed a regression equation of

Y=19380.6X +

71.6 with a correlation coefficient of 0.9855. Y and X represented the fluorescence
intensity and the concentration of Exo III in unit of U/mL, respectively. The limit of
detection (LOD) for the detection of Exo III was calculated to be 0.001 U/mL based on
the slope of the equation (3σ/s), where σ was the standard deviation of four blank
fluorescence intensities and s was the slope of the calibration curve. This ultra-low LOD
demonstrated that the GO-based sensor ensured an ultra-sensitive platform for the
detection of Exo III activity compared with other fluorescent methods (Table 1).
Moreover, the present work only needs one-terminal modification of the DNA probe
compared with our previous work with a molecular beacon, and the superior quenching
ability of GO significantly decreased the background, thus enhancing the sensitivity of
the sensor.

Figure 14. Fluorescence spectra of sensor incubated with different concentrations of
Exo III from 0 U/mL to 20.0 U/mL. (B). The plot of the fluorescence intensity with
different concentrations of Exo III. The inset graph shows the calibration curve of the
sensor. Reaction conditions: 100 nM HP and 20 µg/mL GO in 100 µL 1X NEBuffer 2.
λex = 480 nm, λem = 517 nm.
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Table 1. Comparison of the proposed sensor with other fluorescent methods.
Probes

LOD

Linear range

(U/mL)

Response

Reference

time

Molecular beacons

0.01

0.04 - 8 U/mL

200 s

77

Copper Nanoparticles

0.02

0.05 - 2 U/mL

91 min

91

SYBI green I

0.7

1 - 200 U/mL

110 min

92

G-quadruplex

0.8

5 - 100 U/mL

70 min

75

GO/HP

0.001

0.01-0.5 U/mL

20 min

This work

3.6. Selectivity investigation.
To validate the selectivity of this sensor, we studied the response of the sensor
towards a series of DNA enzymes, including Exo I, T4 PNK, Lambda Exo, RecJf, CIP,
UDG and Exo III, with a concentration of 10 U/mL. Exo I is the enzyme to cut down
single strand DNA from 3´ termini to 5´ termini.93 Lambda Exo removes 5'
mononucleotides from duplex DNA.94 RecJf digests single-stranded DNA specific from
5' termini to 3' termini.95 T4 PNK is hunting for 5' phosphorylation of DNA/RNA for
subsequent ligation.96 CIP is catalyzing the dephosphorylation of 5´ and 3´ ends of DNA
and RNA.97 UDG is a recombinant enzyme that releases uracil from single strand or
double strand DNA. 98 Those DNA enzymes are all very common and play essential
roles in multiple biological processes.99 Therefore, it is important to determine the
selectivity of the senor for Exo III enzymatic activity. As shown in Figure 15, with the
same concentration treatment of these enzymes, only Exo III caused a significant
fluorescence enhancement comparing with other enzymes. These results demonstrated
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that this sensor has excellent selectivity for Exo III detection.

Figure 15. Selectivity of the sensor for Exo III over other enzymes. Reaction conditions:
100 nM HP and 20 µg/mL GO in 100 µL 1X NEBuffer 2. The concentration of enzymes
was 10.0 U/mL. λex = 480 nm, λem = 517 nm.
3.7 Inhibition test.
We further evaluated the inhibition assay of Exo III as it is important for drug
screening. EDTA, as a chelating agent, could effectively inhibit the activity of Exo
III.41 As shown in Figure 16, the fluorescence intensity of the sensor decreased with
the enhanced concentration of EDTA, indicating the inhibition effect of EDTA for Exo
III activity. Half-maximal inhibitory concentration (IC50) of EDTA was estimated to be
3.0 mM. The results demonstrated that this designed sensor could be utilized for the
drug screening specifically for selecting the potential inhibitors of Exo III activity.
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Figure 16. Effect of EDTA concentration on the Exo III activity. Reaction conditions:
100 nM HP and 20 µg/mL GO in 100 µL 1X NEBuffer 2. The concentration of Exo III
was 10.0 U/mL. λex = 480 nm, λem = 517 nm.
3.8. Application in diluted serum sample.
To test the applicability of the sensor, we investigated the performance of the
sensor in fetal bovine serum (FBS). The experiments were conducted at the same
optimized conditions, except that the 1X NEBuffer 2 was replaced with 10-times
diluted FBS with buffer. Similarly, the fluorescence intensity of FAM increased as the
concentration of Exo III increased from 0 U/mL to 5.0 U/mL (Figure 17), with a linear
range between 0.01 U/mL to 0.15 U/mL (the inset of Figure 17B). The calibration curve
showed a regression equation of Y= 14.388 X+1.157 with a correlation coefficient of
0.9741. Y and X represented the fluorescence intensity and the concentration of Exo III
in the unit of U/mL, respectively. The limit of detection (LOD) for Exo III was
calculated to be 0.004 U/mL in 25-times diluted FBS based on the slope of the equation
(3σ/s). The results suggested that the sensor could be used in complicated samples for
the detection of enzymatic activity of Exo III.
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Figure 17. (A) Fluorescence spectra of the sensor upon incubation with different
concentrations of Exo III in 25-times diluted FBS from 0 U/mL to 5.0 U/mL. (B) The
plot of the fluorescence intensity with different concentrations of Exo III. The inset
graph shows the calibration curve of the sensor. Reaction conditions: 100 nM HP and
20 µg/mL GO in 200 µL 25-times diluted FBS. λex = 480 nm, λem = 517 nm.
3.9. Kinetic Analysis.
In order to obtain the kinetic analysis of the enzymatic activity, we performed
the real-time fluorescence measurements using the sensor for different concentrations
of Exo III. As shown in Figure 18, the fluorescence of HP was firstly totally quenched
by the addition of GO, indicating the strong interaction between GO and HP, as well as
the excellent quenching ability of GO towards the fluorophore. When the fluorescence
intensity had stabilized, an aliquot of Exo III with different concentrations was
introduced into the cuvette. The immediate fluorescence record shows a dramatically
fluorescence enhancement after the addition of Exo III, indicating that the rapid
enzymatic reaction in the sensor. The signal-to-background ratio reached about 10.0
when the concentration of Exo III was 1.0 U/mL. The fluorescence intensity reached a
plateau after about 300 s.
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Figure 18. Real-time kinetic analysis of Exo III with different concentrations. From
bottom to top: 0, 0.1, 0.5, 1.0 U/mL
4. Conclusions
In conclusion, we developed a simple and ultra-sensitive fluorescent sensor to
detect the enzymatic activity of Exo III. The design was based on the different affinities
of ssDNA and mononucleotide with GO and the superior quenching ability of GO to
fluorophores. The sensor presented excellent selectivity to Exo III with a LOD of 0.001
U/mL in buffer, and 0.004 U/mL in 25-times diluted FBS. To the best of our knowledge,
the LOD in this assay was superior in the fluorescent method for Exo III detection. The
successful application in complex sample (diluted serum) of the sensor suggested that
this method has the potential to be used for disease diagnosis and drug screening
relating to the enzymatic activity.
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CHAPTER III
ONE POT SYNTHESIS OF GRAPHENE QUANTUM DOTS USING HUMIC
ACID AND ITS APPLICATION FOR COPPER(II) ION DETECTION
1. Introduction
Nanomaterials, due to their unique chemical, physical and optical properties,
have proven to be pivotal tools in multiple biomedical applications.100-107 In particular,
some fluorescent nanomaterials, such as quantum dots and polymer dots, have been
widely used as bioimaging agents. When compared with fluorescent dyes, fluorescent
nanomaterials have shown a major advantage in their photostability, which makes them
an effective new probe for labeling and imaging of cells, tissues and organisms.108-118
Among all the fluorescent nanomaterials, quantum dots, owing to their excellent
properties, attract great attention.119 The bright and stable fluorescence of traditional
semiconductor quantum dots (QDs), such as CdSe and CdTe, caused them to be used
as alternatives to dyes in a number of applications.120-122 They exhibit a broad
absorption, along with a narrow and adjustable emission wavelength. However, the high
cytotoxicity of their heavy metal components constrains their biological applications.
123-127

Graphene quantum dots (GQDs), a new emerging class of quantum dots, have
attracted great attention as a promising fluorescent probe due to their unique
characterizations including good water solubility, excellent photoluminescence, low
toxicity,

biocompatibility

and

high

resistance

to

photodegradation

and

photobleaching.128-130 In general, GQDs are synthesized from carbon-based materials.
Basically, there are two main strategies: top-down and bottom-up methods. The topdown methods include acidic exfoliation, electrochemical oxidation and hydrothermal
synthesis, which break large-sized materials to small-sized GQDs. Some physical
methods like sonication will accelerate the formation of GQDs. The top-down methods
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bring oxygen-containing functional groups to the edges of GQDs, promoting the
solubility and simplifying modification for specific purposes.127 However, the
purification procedure is time-consuming because of the highly concentrated salt in the
solution. In contrast, bottom-up methods utilize small carbon-based precursors to form
graphene quantum dots.128 These approaches offer possibilities of doping multiple
heteroatoms on graphene quantum dots to enrich their intrinsic properties for further
applications. Unfortunately, the synthesis process always suffers from low utilization
of starting materials, low yield of production and aggregation.
There are abundant raw materials to produce GQDs; the starting materials of
top-down methods could be summarized as large graphene-based materials, such as
graphite, graphene sheets, carbon nanotubes and fibers.129 However, these materials are
relatively expensive, which leads to a higher cost for scaled-up production. The bottomup methods use low molecular weight carbon-based precursors.130 Up to now, only a
few low molecular weight compounds including citric acid, glucose and amino acids
have been used for fabricating graphene quantum dots.131-133 Recently, humic acid, a
higher molecular weight organic compound, has been extracted from a broad range of
raw materials, such as peat, soils, black coals, dystrophic lake, sea sediments and other
natural materials.134 In general, humic acid could be considered as a byproduct of
biological or chemical decompositions of plant and animal residues. Thus, there is no
absolute static structure for humic acid due to the diversity of humification pathways.
It has been proposed that most humic acids have large conjugated double bonding area
and aromatic ring structures as the main matrix, together with multiple chemically
reactive functional groups such as carboxyl, aldehydes, ketones, phenols, alcoholic
hydroxyls and quinones, which provide the possibilities of chelating interactions to
some specific ions. Comparing with graphene-based starting materials, humic acid
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contains similar highly conjugated sp2 carbon hybridization domains, aromatic and
benzene ring structures. Therefore, humic acid would be qualified to serve as a new
carbon source to synthesize graphene quantum dots.135 In the last few decades, the
technology to extract humic acid from industrial waste and straw has provided
sufficient supplies for the production of GQDs.136
In this chapter, we have successfully fabricated highly fluorescent GQDs using
humic acid. The preparation was conducted by hydrothermal treatment of humic acid
in an autoclave at 200 oC for 12 h. The results of FTIR and XPS exhibited plentiful
functional groups on the GQDs. Fluorescence and UV-Vis spectroscopy analysis
showed a high yield of ca. 20% of GQDs. Compared with other methods to produce
GQDs, using humic acid as a precursor would reduce the cost for scaled-up production
to a great extent due to the existence of abundant humic acid in the environment.
Furthermore, the application of the GQDs was demonstrated by its sensitive
fluorescence response to Cu2+, which was based on chelation-induced aggregation. The
method showed a limit of detection of 0.44 M Cu(II) in buffer and a linear range from
0 M to 40 M Cu(II).

2. Experimental Section
2.1. Chemical and materials.
Humic acid was obtained from Advanced Material Characterization
Laboratory of Institute for Energy Studies. Ammonium hydroxide (NH4OH, 28.0% –
30.0%), (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid) HEPES and sodium
hydroxide were obtained from Sigma-Aldrich. Sterile syringe filters ( 0.45 m cellulose
acetate ) were provided by ThermoFisher Scientific. High purity liquid argon and ultrahigh purity helium gas obtained from Airgas were used in the ICP-MS measurements.
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The 100 ppm Cu, Sc, and Rh stock solutions provided from Inorganic Ventures were
used during the ICP-MS measurements. All chemicals were analytical reagent grade
unless specified. All buffer solutions were prepared using ultrapure water (18 MΩ·cm)
from a Millipore Milli-Q water purification system. Copper(II) sulfate was purchased
from Sigma-Aldrich.
2.2. Synthesis of the GQDs.
The GQDs was produced by a simple hydrothermal method. Briefly, 10.0 mg
of humic acid was dispersed in 10.0 mL 0.01 M NaOH aqueous solution and then the
pH was optimized to about 10. The black solution was sonicated and transferred into a
25.0 mL Teflon-lined stainless-steel autoclave. The reaction temperature was heated up
to 200 ℃ for 12 h in an oven. After the autoclave was cooled down to room temperature,
and the solution had turned brown. Finally, the solution was centrifuged at 10,000 rpm
for 20 min to remove the large particles, and the supernatant was further dialyzed in a
dialysis bag (molecular weight cutoff = 10,000) for 48 h to remove small molecules.
2.3. Characterization of the GQDs.
A JEOL JEM-2100 high-resolution transmission electron microscope
(HRTEM) (JEOL Ltd., Tokyo, Japan) was used to take images of the GQDs with the
voltage condition at 200 kV. The size distribution of the GQDs was recorded from
Zetasizer Nano ZS (Marlwen, Worcestershire, UK). A PerkinElmer Lambda 1050
UV/VIS/NIR spectrometer (PerkinElmer, Santa Clara, CA, USA) was used to obtain
the absorption spectra of the GQDs. Fluorescence measurements were performed on a
RF-6000 fluorophotometer (SHIMADZU, Kyoto, Japan). The excitation wavelength
was 360 nm and the emission was recorded from 380 nm to 700 nm. The fluorescence
intensity at 470 nm was selected to evaluate the performance of Cu2+ detection. Both
the widths of excitation and emission slits were 10.0 nm. All the experiments were
42

carried out at 25 oC. A FT-IR Spectrum ATR iD5 spectrometer (ThermoFisher Scientific,
Waltham, UK) was used to collect the Fourier transform infrared (FTIR) spectra of
GQDs. The X-ray photoelectron spectroscopy (XPS) measurements was performed on
a PHI-5400 X-ray photoelectron spectrometer (ULVAC-PHI, Japan) with 10-10 Torr
base pressure. The Al Kα (1486.6 eV) X-ray radiation was used as the X-ray source,
powered at 300 W for excitation. An X-ray diffraction spectrum was recorded on a
Smartlab-3KW X-ray Diffractometer (Rigaku, Tokyo, Japan). Teflon Lined
Hydrothermal Synthesis Autoclave Reactor (APT, RI, USA). PTFE Lined Vessel (25
mL) was used to synthesize GQDs. VWR Symphony Vacuum Oven (VWR, PA, USA).
was utilized to increase the temperature to 200 oC. An iCAP Qc ICP-MS ( Thermo
Scientific, Bremen, Germany) combined with a 4-channel 12-roller peristaltic pump
and a Teledyne CETAC ASX560 autosampler (Omaha, NE) was used to monitor the
Cu concentrations in Red Revier water samples. The THERMO-4AREV (Thermo
Scientific) standard was run daily to optimize the ICP-MS with maximum 59Co,
and minimum

140

238

U

Ce/140Ce oxide signal in the kinetic energy discrimination. The ICP-

MS measurements of Cu concentraions were collected using the QtegraTM software
(version 2.8.2944.202). The isotopes 45Sc and

103

Rh were used as internal standard in

the ICP-MS measurements.
2.4. Effect of pH and photostability
1.0 mL of 1.0 mg/mL GQDs solution was incubated in different pH buffer,
ranging from 1 to 12 for 1 hour. Then, the fluorescence intensity of the GQDs solution
at different pH was recorded. In order to investigate the photostability of GQDs, a timebased fluorescence collection was performed with 1.0 mL 1.0 mg/mL GQDs solution
for 1800 s. FITC was used as a control group.
2.5. Quantum yield measurement
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Quinine sulfate in 0.1 M H2SO4 (QY = 0.54 at 360 nm) was chosen as a
standard for quantum yield measurement. The quantum yield of the GQDs was
calculated according to the following formula:
𝐺𝑟𝑎𝑑

𝜂2

Φ𝑥 = Φ𝑠𝑡 (𝐺𝑟𝑎𝑑 𝑥 )(𝜂2𝑥 )
𝑠𝑡

𝑠𝑡

Φ𝑥 is the quantum yield. Grad is the gradient from the plot of integrated

fluorescence intensity vs absorbance and η is the refractive index of the solvent (1.33
for water). The subscript “st” stands for the reference standard of known quantum yield
and "x" for the sample. In order to minimize reabsorption effects, absorbances in the 10
mm fluorescence cuvette were kept under 0.1 at the excitation wavelength (360 nm).
2.6. Copper(II) ion induced aggregation analysis
In order to demonstrate the strategy for this Cu2+

detection, as a stronger

chelator, same molar amount (40 µM) of EDTA as Cu2+ was together added into the 0.4
mg/mL GQDs solution. In two parallel experiments, one only contained 0.4 mg/mL
GQDs, the other contained an aliquot of 40 µM of Cu2+ mixed with 0.4 mg/mL GQDs.
All of the fluorescence intensity was measured with an excitation wavelength of 360
nm. The fluorescence signal at emission wavelength of 470 nm was recorded.
2.7. Copper(II) ion detection procedure.
In order to investigate the quenching ability of Cu2+ on GQDs, we incubated
the 1.0 mL of 0.4 mg/mL GQDs with different concentrations of Cu2+

for 12 h. Then,

the fluorescence intensity at 470 nm with excitation of 360 nm was recorded for each
concentration. The concentration of Cu2+ ranged from 0 to 300 µM.
2.8. Selectivity investigation of GQDs.
In order to investigate the selectivity of GQDs on different metal ions, 1.0 mL
of 1.0 mg/mL GQDs solution was added with different metal ions, including, Ni2+, Ca2+,
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Co2+, Cd2+, Mg2+, Cu2+, Zn2+, Fe3+, Mn2+, Na+, K+, Ag+, and Pb2+. The concentrations
of the metal ions were fixed at 20 µM. All the fluorescence intensity was measured with
the excitation wavelength of 360 nm. The fluorescence signal at emission wavelength
of 470 nm was recorded.
3. Results and Discussion
3.1.Formation and design of the highly fluorescent GQDs
A simple bottom-up method was developed to fabricate GQDs from humic
acid by a one pot hydrothermal reaction. The formation of GQDs is illustrated in
Scheme 3. Firstly, in order to enhance the solubility of humic acid, the pH of distilled
water was adjusted to 10 by ammonium hydroxide; during this process, humic acid was
well dispersed and formed into a dark black solution. Afterwards, an aliquot of 10.0 mL
of the above solution was transferred into autoclave and put into an oven whose
temperature was set to be 200 ℃ for 12 h. After purification by dialysis, the highly
fluorescent GQDs were obtained. Interestingly, the fluorescence intensity of this
specific GQDs showed strong response to Cu2+ (Scheme 3). In the presence of Cu2+,
the carboxylic groups on the GQDs might chelate with Cu2+ and lead to a significant
aggregation of GQDs, which cause a noticeable decrease of the fluorescence intensity.
In order to prove this theory, same concentration of EDTA and Cu2+ was added together
into graphene quantum dots, it was found that the fluorescence intensity would recover
with the help of EDTA(Figure 19).
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Scheme 3. Schematic illustration of the formation of GQDs and its application for Cu2+
detection.
1.5

DF/F0

1.0

0.5

0.0
GQDs+Cu2+ GQDs+Cu2++ EDTA

GQDs

Figure 19. The Cu2+ induced aggregation could be reversed by introducing EDTA into
solution. Reaction condition: pH 7.0, 20 mM HEPES, 0.4 mg/mL GQDs, 40 µM Cu2+,
40 µM EDTA, λex = 360 nm, λem = 470 nm.
3.2. Characterization of graphene quantum dots
To characterize the morphology of the GQDs, a high resolution TEM was
performed, (Figure 20). The lattice spacing of GQDs from the Figure 20(c) is about
0.286 nm, indicating the characteristic structure of the graphitic carbon. The size
distribution measured by the DLS is shown in Figure 20(d), indicating the uniform size
distribution of hydrodynamic diameters (6.5 ± 2.3 nM). XRD was also performed to
characterize the graphitic nature of the GQDs. As shown in Fig. 21, there was a broad
peak centered at 2θ = 25°, corresponding to an interlayer spacing of 0.286 nm, which
may be caused by the graphite (002) planes. The result was consistent with other paper
reported on GQDs.131
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Figure 20. (a),(b) TEM images of the GQDs. (c) HRTEM image of the GQDs
(0.286 nm). (d) The size distribution of the GQDs detected by DLS.

Figure 21. XRD patterns of the GQDs.

FT-IR spectroscopy and X-ray photoelectron spectroscopy (XPS) are
commonly used to study the surface groups of the GQDs and analyze their components.
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The composition of the obtained GQDs was characterized by XPS (Figure 22). The
results showed two main peaks at 285.25 eV, and 432.5eV, which can be attributed to
C 1s and O 1s, respectively. The atomic percentage of the carbon and oxygen were
calculated be about 80 % and 20 %, respectively, which were the main elements in the
GQDs. The C 1s spectrum of GQDs (Figure 22 b) showed five component peaks ,
including at 284.2 eV, 284.9 eV, 286.2 eV, 288. 2 eV and 288.9 eV indicated the
presence of C=C, C-C/C-H, C-OH, C=O and -COOH, respectively. All these data from
XPS analyses suggested that the C and O atoms existed in GQDs. These functional
groups, including carboxyl groups, enabled the modification potential for future
applications.
(a)

(b)

Figure 22. (a) Survey XPS spectra of the GQDs. (b) High resolution C 1s spectra of the
GQDs.
FTIR was used to demonstrate the existence of various functional groups on
GQDs. As shown in Figure 23, the peaks at 1070 cm-1, 1250 cm-1 and 1400 cm-1
indicated the presence of the C-O-C, C-O and N-H stretching in graphite structure. The
presence of carboxyl groups was proved by the broad peak area at 2970 cm-1 and the
sharp peak at 1600 cm-1. Besides the carbon related functional groups; the amine N-H
functional group showed stretching vibrations of amine N-H at 3000 – 3500 cm-1.
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Humic acid

GQDs

Figure 23. The FT-IR spectra of the GQDs and Humic acid.
3.3. Fluorescent properties.
Under the irradiation of 365 nm UV light, the GQDs showed strong white blue
fluorescence (Figure 24A), indicating the formation of the fluorescent GQDs and a
broad emission band. The excitation and emission spectra of GQDs were shown in
Figure 24B. The strongest fluorescence emission was obtained when the excitation
wavelength was set to 340 nm. Upon excitation at 340 nm, GQDs showed a strong
fluorescence peak at 470 nm. In Figure 24C, the UV-Vis absorption spectrum of the
GQDs aqueous solution showed a typically optical absorption in the ultraviolet (UV)
region with a long tail expanding into the visible range. There is no obvious peak except
the peak near 260 nm, which corresponding to a π to π* transition of aromatic C=C
bonds. In Figure 24D, the graphene quantum dots showed excitation-dependent
emission. When the excitation wavelength increased from 260 nm to 560 nm, the
emission wavelength increased from 440 nm to 590 nm. This excitation-dependent
manner was consistent with most of the fluorescence properties of graphene quantum
dots. In table 2, the morphology, color, quantum yield, stoke shift and preparation
procedure of blue emission GQDs of some different methods were summarized and
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compared. Both the quantum yield and stoke shift showed superior advantages than
other GQDs, the preparation procedure was simpler, and the starting materials was
lower cost.
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Figure 24. (A) photographs of humic acid (b) and GQDs (a) excited under 365 nm UV
light). (B) Upon excitation at 340 nm, GQDs emit fluorescence peak at 470 nm. (c) UVvis absorption spectrum of humic (a) and humic acid GQDs (b). (D) Fluorescence
spectra the excitation wavelength increased from 260 nm to 560 nm, the fluorescence
emission peak shifted from 440 nm to 590 nm.
Table 2. Comparison of this work with other methods of GQDs.
Methods

Starting
Materials

Size (nm)

Color

Quantum yield
(%)

Excitation, Emission
Stoke Shift

Procedure,
Reaction time

Reference

Acidic
Oxidation

Carbon
black

~18

Yellow

9.0

365 nm, 440 nm
75 nm

One pot, 24 h

137

Microwave

GO

2-7

Green,
Blue

8.0

340 nm, 450 nm
80 nm

Multiple
procedures

138

GO

5-13

Blue

5.0

320 nm, 430 nm
110 nm

Multiple
procedures

139

Graphite
flakes

~20

Blue

9.9

316 nm, 423 nm
107 nm

Multiple
procedures

140

Citric acid
thiourea

~15

Blue

14.5

369 nm, 444 nm
75 nm

One pot, 2 h

141

Humic
acid

~6

White,
Blue

20

340 nm, 470 nm
130 nm

One pot, 12 h

-

Hydrothermal

K intercalation
Precursor
pyrolysis

This work
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3.4. pH effect, photostability and stability on metal ions
In order to test the feasibility of the GQDs for bioimaging and biosensing, the
photostability of GQDs were investigated. They exhibited superior photostability
compared with the organic dyes, FITC. It was observed that no photobleaching
appeared at a long irradiation period of 30 min (Figure 25A). In Figure 25B, the
fluorescence intensity of GQDs showed significant difference at different pH. The
emission intensity at 470 nm was used to compare from pH 1.00 to pH 12.00, the
fluorescence intensity elevated when the pH of the GQDs solution increased from 1.00
to 9.00. Under strong basic condition from pH 10 to pH 12, the intensity was weakened.
In particular, the emission exhibited stable fluorescence signal in the pH range of 5.00
to 9.00, indicating its applicability in physiological environments.
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Figure 25. Photostability(A) and pH effect (B) of the GQDs
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Moreover, we investigated the effect of different metal ions on the
fluorescence intensity of GQDs. As shown in Figure 26B, a series of different metal
ions were tested at the concentration of 20 µM. It showed that Cu2+ induced a
significantly better fluorescence quenching than other metal ions.
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Figure 26. Effects of different ions (20 µM) on the fluorescence intensity of graphene
quantum dots.
3.5. Experiment condition optimization.
In order to demonstrate the optimal conditions for reacting with Cu2+, the
effects of the concentration of GODs, the pH and the reaction time on the precipitation
performance were studied.
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Figure 27. The effect of concentration of graphene quantum dots on the sensitivity of
the assay. F referred to the fluorescence intensity of different concentrations of quantum
dots treated with 50 µM Cu2+ in 20 mM HEPEs ( pH 5.0)
λex = 360 nm, λem = 470 nm.
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The concentration of GQDs was the first condition that required to be
determined. A list of concentrations of GQDs were sonicated with 50 M Cu2+ in 20
mM HEPES at pH 5.0 overnight. The fluorescence intensity of the above solution was
recorded and designated as F. As a control, the same concentration of GQDs kept
stirring overnight with adding the same amount of water only, the fluorescence intensity
was defined as F0. The corresponding ratios of F to F0 reached minimum value at the
concentration of 0.40 mg/mL of GQDs, indicating the optimal sensitivity at this
concentration. Therefore, we utilized the concentration GQDs at 0.40 mg/mL for the
following experiments.
Additionally, the optimal pH and reaction time were required to be considered
to reach the optimal result. The fluorescence intensities of GQDs at different pH were
tested to evaluate the optimal pH. As shown in Figure 28, F0 refers to the fluorescence
intensity of 0.4 mg/mL GQDs without Cu2+, and F refers to the fluorescence intensity
of 0.4 mg/mL GQDs after the addition of 50 µM Cu2+ at various pH conditions. The
ratio of F/F0 was enhanced as the pH value elevated, indicating the pH-dependent
quenching ability of GQDs. Obviously, at pH 5.0, the fluorescence quenching reached
the lowest value, therefore the following experiments was performed at pH 5.0.
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The time optimization was also tested in Figure 29, F0 refers to the
fluorescence intensity of 0.4 mg/mL GQDs at various time period as a control , and F
refers to the fluorescence intensity of 0.4 mg/mL GQDs with the addition of 50 µM
Cu2+ at various time period. It was observed that after 12 hours, the curve has reached
plateau. Consequently, the reaction time was set to 12 hours.
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Figure 28. The effect of pH on the sensitivity of the sensor. F refers to the fluorescence
intensity of different pH of the same concentration of quantum dots treated with 50 µM
Cu2+ in 20 mM HEPEs (pH 5.0) λex = 360 nm, λem = 470 nm.
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Figure 29. The effect of reaction time on the sensitivity of the essay. F refers to the
fluorescence intensity of different pH of the same concentration of quantum dots treated
with 50 µM Cu2+ in 20 mM HEPEs (pH 5.0) λex = 360 nm, λem = 470 nm.
3.6. Cu2+ detection.
To analyze the sensitivity of the GQDs towards Cu2+, 0.4 mg/mL of GQDs
solution was mixed with various concentrations of Cu2+ for 12 h at room temperature
54

in 20 mM HEPES buffer at pH 5.0, the corresponding fluorescence intensity was
recorded. As shown in Figure 30A, the fluorescence intensity of GQDs decreased as
the concentration of Cu2+ increased from 0 µM to 300 µM. The curve showed that the
dynamic range was from 0 µM L to 300 µM (Figure 30), with a linear range between 0
µM to 40 µM (the inset of Figure 30B). The calibration curve showed a regression
equation of Y= 90.21X + 63.59 with a correlation coefficient of 0.9984. Y and X
represent the fluorescence intensity and the concentration of Cu2+ in unit of µM,
respectively. The limit of detection (LOD) for the detection of Cu2+ was calculated to
be 0.44 µM based on the slope of the equation (3σ/s), where σ was the standard
deviation of three blank fluorescence intensities and s was the slope of the calibration
curve. This LOD could ensure the Cu2+ detection in drinking water, because the
Environmental Protection Agency (EPA) has required the highest concentration level
of Cu2+ in drinking water to be 20 µM. Therefore, this essay is qualitied for the drinking
water monitoring.142
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Figure 30. Fluorescence spectra of quantum dots incubation with different
concentrations of Cu2+ in 20 mM HEPES (pH 5.0) from 0 µM to 300 µM. (B). The plot
of the fluorescence intensity with different concentrations of Cu2+. The inset graph
shows the calibration curve of the sensor. λex = 360 nm, λem = 470 nm. (LOD: 0.44 µM)
3.7. Analysis of spiked sample.
To validate GQDs as a Cu2+ sensing reagent, a series of different
concentrations of Cu2+ was added into the Red River water as spiked samples (Table 3).
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The final Cu2+ concentration was 10 µM and 20 µM. The ICP-MS method was
performed as a standard method to compare with this Cu2+ GQDs sensing approach.
The results showed a good correspondence for both samples.
Table 3. Comparison of the spike recovery of ICP-MS Methods with Designed GQDs
essay.

4. Conclusions
We have developed a facile procedure to produce the blue emissive graphene
quantum dots using humic acid that were extracted from soil, peat, and coal. The
fluorescence intensity of this new developed quantum dots was proportional to the
concentration of Cu2+ based on its fluorescence quenching to GQDs. The optimized
assay provided a linear range from 1 µM to 40 µM Cu(II), and a detection limit of 0.44
µM Cu (II). The method was used to test red river by spiking Cu(II). The accuracy was
proved by inductively coupled plasma mass spectrometry (ICP-MS).
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CHAPTER IV
TWO READOUTS SENSOR USING EU COORDINATED MEH PPV POLYMER
DOTS FOR THE DETECTION OF COPPER (II) IONS
Introduction
Metal pollution has been considered as a serious safety issue due to its wide
and long-term effect.143 Therefore, metal ion monitoring in river, lake and other natural
resources is significantly necessary for environmental protection and ion cycling in
biological systems.144 In order to accurately monitor the metal ion concentrations, it
is essential to conceive the basic principles and benefits for different methods on metal
analysis. There were plenty of analysis methods for elemental analysis, including
atomic absorption/emission spectrometry (AAS/AMS), induced coupled plasma mass
spectrometry (ICP-MS), fluorescence methods and nuclear techniques.145-150 Each of
those methods utilized one signal to quantify the amount of element. Among all these
methods, fluorometric methods have been regarded as a faster and simpler methodology,
the diversity of fluorescence probes including all kinds of nanomaterials, such as
organic dyes, quantum dots, nanoclusters and semiconducting polymer dots.151-153
However, those fluorescent nanoprobes suffer from the same limitations, such as high
background noise in some complex matrix, photobleaching problems of fluorescent
probes and high limit of detection.154 Besides, most of the detection limit of fluorescent
nanoprobe is in the micromole range, which would prevent their further application in
low detection range such as nanomolar detection. In order to improve the feasibility of
the fluorescent nanoprobe in low detection range, a single pattern of fluorescence signal
could not suffice, an ultrasensitive signal is required to play a role in this sensing system
to construct a two readouts nanoprobe.
Recently, a new technology called single particle inductively coupled plasmamass spectrometry (spICP-MS) has emerged as a promising analytical approach for
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metal-containing nanoparticles in an aqueous matrix.155 During the sample acquisition
time period, each metal-containing nanoparticle was ionized by a plasma torch,
producing an ion cloud containing the target isotope. Within one dwell time period, a
single particle was controlled to be collected and shown as one single peak.
Consequently, one peak represented the detected metal signal from one single particle.
The intensity of the isotope peak is directly proportional to the amount of metal element
doped in a single nanoparticle. Most importantly, spICP-MS is a “particle by particle”
detection process which requires all the particle solutions to be detected at an extremely
low concentration. Each single spike exhibits the isotopic signal collected from the
detected metal doped nanoparticle and high intensity of the spike represents the more
Eu element in one single nanoparticle. Theoretically, if two nanoparticles aggregated
together, a higher intensity will be recorded, the more nanoparticles are agglomerated,
the higher intensity will be detected, while the spike number will be reduced, which
makes spICP-MS an effective tool for ultrasensitive assay. Therefore, spICP-MS signal
would be a good output to improve the fluorescent nanoprobe.
A two readouts nanoprobe was developed to achieve excellent sensitivity, a
broad linear range and absolute nanoparticle concentration quantification. Eu3+, as a
lanthanide element, is one of the rarest rare metal elements on the earth and shows little
toxicity when compared with other heavy metals. Therefore Eu3+ is a suitable metal
isotope to be applied in spICP-MS analysis because of the lower background signal.
When considering a suitable matrix to combine both a spICP-MS signal and a
fluorescence signal, semiconducting polymer nanoparticles (SPNs) would be a great
choice to fulfill the purpose. There are three main advantages for using SPNs. First,
SPNs could be designed to contain a large amount of metal ions that will enhance the
spICP-MS signal versus background noise. Second, semiconducting polymer
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nanoparticles exhibit superior fluorescence properties, such as high quantum yield,
large Stokes shift, and high photostability. Third, the synthesis process of lanthanide
doped SPNs is simple, without a tedious purification protocol.156 Considering this, a
novel two-readouts nanoprobe fabricated from Eu3+-coordinated MEH-PPV polymer
nanoparticles was designed.
Copper, as a pivotal metal in human life, is involved in various physiological
functions in biological activities, especially in cell generation and enzymatic
processes.157-158 However, copper exhibits high toxicity if over-ingested. For example,
through the food chain, copper has been proved to be a direct reason to increase the
outbreak rate of multiple serious neurodegenerative diseases, such as Wilson and
Parkinson’s.159-160 In addition, Cu2+ disturb the normal functioning of organs, including
gastrointestinal, kidney and liver.161 The identification and measurement of copper ions
(Cu2+) in environmental matrices and biological fluids are in great need. Thus, we chose
copper as a model to test the applicability of this two readouts nanoprobe. Taking
advantage of the paramagnetic properties of Cu2+, many fluorescence probes have been
designed to detect fluorescence signals influenced by Cu2+ ions. In addition, Irving–
Williams Series proves that transition metal Cu2+ has tendency to form complex with
carboxylic groups. The aggregation induced fluorescence quenching, the mechanisms
include photoinduced electron transfer, fluorescence resonance energy transfer, charge
transfer and some other interactions that occurred at the fluorescence nanoprobe
surface.162-167
In this chapter, a novel two-readouts sensor fabricated from Eu3+-coordinated
MEH-PPV polymer nanoparticles was designed for the detection of copper ion (Cu2+).
One readout was based on the fluorescence signal emitted by the fluorescent matrix of
MEH-PPV polymer nanoparticles. Cu2+, compared to other element ions, have efficient
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chelating interactions with carboxylic groups. They will be captured by carboxylic
groups on the polymer nanoparticles and result in a significant fluorescence quenching.
The other readout was based on the Eu mass signal from SPN-Eu; the aggregation of
the SPN-Eu not only causes the fluorescence quenching but can also increase the size
of the particle and decrease the spike numbers, which could be quantitated by singleparticle inductively coupled plasma mass spectrometry (ICP-MS). Therefore, the
concentration of Cu2+ would be proportional to both the fluorescence and ICP-MS
signals. This assay provides a rapid and selective detection method for Cu2+ with an
extremely low detection limit, indicating its superior potential applied in environmental
monitoring.

2. Experimental Section
2.1. Materials and Instruments.
Poly[2-methoxy-5-(2-ethylhexyloxy)-1,4-phenylenevinylene]

(MEH-PPV,

average molecular weight is 40,00070,000), europium(III) chloride, 4-(2hydroxyethyl)piperazine-1-ethanesulfonicacid, (HEPES, 99.5%, ACS grade), copper(II)
sulfate, potassium chloride, sodium chloride, magnesium(II) sulfate, zinc(II) sulfate,
manganese(II) dichloride, lead(II) sulfate and tetrahydrofuran (THF, 99.9%, inhibitorfree, ACS grade) were purchased from Sigma Aldrich. Poly(styrene-co-maleic
anhydride) (PSMA) was purchased from Polymer Source Inc. and used as received
without further purification. Ultra-purified water (18.3 MΩ cm) used in all experiments
was obtained using a Milli-Q Millipore water purification system.
A UV/VIS/NIR Spectrometer (Lambda 1050, PerkinElmer) was used to
measure the absorption of samples. Fluorescence measurements were performed on a
RF-6000 fluorophotometer (SHIMADZU). The excitation wavelength was set to be
60

480 nm and the emission was recorded from 500 nm to 700 nm. The fluorescence
intensity at 560 nm was selected to evaluate the performance of SPN-Eu probe for Cu2+
detection. Both the widths of excitation and emission slits were 10.0 nm. All the
experiments were carried out at room temperature. A Zetasizer particle analyzer (Nano
 ZS, Malvern) was used to measure hydrodynamic diameters and surface charges of
nanoparticles. A Hitachi 7500 transmission electron microscope (TEM) and a scanning
electron microscope (SEM, SU8010, Hitachi) were used to obtain the morphology of
the synthesized nanoparticles. An iCAP Qc ICP-MS (Thermo Scientific, Bremen,
Germany) was used to all the spICP-MS measurements. Samples were introduced using
a Teledyne CETAC ASX560 autosampler (Omaha, NE), a 4-channel 12-roller
peristaltic pump, a microflow perfluoroalkoxy nebulizer and a Peltier-cooled quartz
cyclonic spray chamber. The sample flow rate was set to ~ 0.20 mL min-1. The ICPMS was tuned daily for maximum

238

U and minimum

140

Ce16O/140Ce oxide level (<

0.03) with THERMO-4AREV (Thermo Scientific) standard solution in STDs mode.
Detailed information about the ICP-MS operation parameters are provided in Table 4.
The dwell time and data collection time for all the spICP-MS measurements were 10
ms and 180 s. Isotope

153

Eu intensity was recorded using QtegraTM software (version

2.8.2944.202).
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2.2. Synthesis of the Eu coordinated MEH-PPV semiconducting polymer nanoparticles
(Eu-SPN).
First, an aliquot of 15 L of EuCl3 solution (10 mg/mL) was mixed with 4.4
mL of THF, followed by adding 500.0 L of 1.0 mg/mL PSMA solution, and then
stirred for one hour. Second, an aliquot of 50.0 L of 0.50 mg/mL MEH-PPV polymer
was added to reach the final volume of 5.0 mL. Then, each aliquot of 5.0 mL of the
above solution was quickly injected into 10.0 mL of DI water under ultrasonication in
the ice bath for about 1.0 min. Finally, THF solvent was evaporated on a hot plate.
2.3. Characterization of Eu-SPN.
The TEM was employed to image the structure of Eu-coordinated
semiconducting polymer nanoparticles (Eu-SPN). The hydrodynamic diameter and
surface potential of the Eu-SPN were characterized using the nano sizer. The elemental
analysis was performed using EDS.
2.4. Cu2+ detection using the fluorometric method and spICP-MS
An aliquot of 100.0 µL of 5.0 ppm of Eu-SPN solution was incubated with
different concentrations of Cu2+ for 1.0 h in a HEPES buffer solution (20 mM, pH 7.0)
to reach a total volume of 1.0 mL at room temperature with regular shaking. Then, with
the excitation of 480 nm, the fluorescence intensity of Eu-SPN at 560 nm was recorded
at each Cu2+ concentration. The concentration of Cu2+ ranged from 0 to 80 µM. For
spICP-MS detection, the above prepared Eu-SPNs were first diluted to 104 particles/mL
with DI water and then introduced into spICP-MS.
2.5. Selectivity investigation of SPN-Eu in Fluorometric and spICP-MS Methods.
In order to investigate the sensitivity of SPN-Eu on different metal ions, 1.0 mL of 1.0
ppm of SPN-Eu solution was added with different metal ions, Pure water was used as
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a control. The concentrations of the metal ions were fixed at 50 µM. For the selectivity
in spICP-MS assay, the samples were performed at the sample reaction condition but
with a series of metal ions at the concentration of 1.0 µM.
3.0. Results and Discussion
3.1. Design of the Eu-SPN sensing platform
In this work, we designed an Eu-SPN Cu2+ nanoprobe with high fluorescence
and high spICP-MS signals. In the beginning, PSMA polymer was hydrolyzed to
functionalize the carboxylic groups, and then followed by adding EuCl3 THF/ethanol
solution with vigorous stirring for 2 h (Scheme 4). During this period, PSMA served as
a highly efficient absorbent to extract Eu3+ by the spontaneous chelation interactions.159
After the immobilization, MEH-PPV polymer was blended in, and then the whole
polymer mixture was injected into water with sonication in ice bath to form Eu-SPN.
For this two-readout copper nanoprobe, one readout was fluorescence signal from the
fluorescent MEH-PPV polymer, the other one was provided by the heavy loading of
Eu3+ ions in Eu-SPN. Cu2+, compared with other element ions, have efficient chelating
interactions with carboxylic groups, which results in nanoparticle aggregation as well
as a significant fluorescence quenching. Higher Cu2+ concentration resulted in higher
aggregation. Meanwhile, in the presence of Cu2+, the aggregation induced an increased
spICP-MS intensity and a decreased number of the spikes. In the single particle analysis
mode, the number of Eu-SPN entering the plasma could be quantified by counting the
spikes. One spike refers to one particle, before adding Cu2+. After adding Cu2+, two or
more nanoparticles agglomerated together went through the plasma. This caused the
signal intensity to be enhanced but the number of pulses to decrease, which directly
corresponded to the Cu2+ concentration. The spICP-MS can detect less than 100 EuSPN per mL, which is extremely lower than the LOD of the fluorescence signal detected
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by a fluorophotometer. We believe that this assay will provide a rapid and selective
detection of Cu2+ with an extremely low detection limit.

Scheme 4. Schematic illustration of Cu2+ detection by Eu coordinated MEH-PPV
semiconducting polymer nanoparticles.
3.2. Synthesis and characterization of Eu-SPN
To prepare the designed SPN-Eu, PSMA was first hydrolyzed to produce two
carboxylic groups at each unit on the polymer chain (Scheme 4 a). With the assistance
of chelating interactions between two adjacent carboxylic groups, Eu3+ was doped on
the PSMA chains during the stirring (Scheme 4 b). After adding MEH PPV fluorescent
polymer, carboxylic functionalized Eu-SPN was formed during the process of
nanoprecipitation The morphology and size of SPN-Eu was characterized with a regular
transmission electron microscope (TEM) and dynamic light scattering(DLS), as shown
in Figure 31, SPN-Eu showed round-shaped well-dispersed nanoparticles, the zeta
potential and hydrodynamic size of Eu-SPN and SPN were also tested. The
hydrodynamic size was significantly increased after doping Eu3+ into the MEH-PPV
polymer nanoparticles. The zeta potential of SPN-Eu and SPN were both lower than 20 mV, ensuring the doping process won’t affect the relative stability of the SPN-Eu in
the aqueous solution.
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Figure 31. (A) TEM image of SPN-Eu ( 500 nm) (B) TEM image of SPN-Eu (200 nm)
(C) Size distribution and zeta potential (pH 7.0 10 mM HEPES) of MEH PPV SPN and
MEH PPV- Eu3+ SPN
3.3. Feasibility investigation of Cu2+ detection using fluorescence and spICP-MS.
To demonstrate the feasibility of Cu2+ detection using spICP-MS, the effective
peak number from SPN-Eu without Cu2+ during the acquisition period was required.
Furthermore, to guarantee single nanoparticle collected in each dwell time during
spICP-MS measurements, particle number concentration of SPN-Eu was investigated.
As shown in Figure 32a-f, the particle number concentration of SPN-Eu ranging from
5.0×103, 1.0×104, 2.0×104, 3.0×104 to 5.0×104 Particles per mL was introduced into the
spICP-MS. For SPN-Eu, with the increasing of particle number concentration, the
collected peak number increased.
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Figure 32. Increasing the particle number concentrations of Eu-SPN (a: 0 P/mL, b:
5.0×103 P/mL, c: 1.0×104 P/mL, d: 2.0×104 P/mL, e: 3.0×104 P/mL, f: 5.0×104 P/mL).
(153Eu, dwell time: 10 ms).
However, increasing the particle number concentration to 5.0×104
Particles/mL, the baseline from isotope Eu increased as well. The multiple
nanoparticles would be monitored in each dwell time, which led to continuous spikes
instead of individual spikes. The results showed that the concentration at 1.0×104 P/mL
contained both high spike number and individual spikes. Consequently, before injecting
into the spICP-MS, the particle number concentration was diluted to 1.0×104 P/mL in
the following experiments.

Figure 33. spICP-MS spectra of Eu-SPN in the presence of Cu2+ at 100 µM (a: 0 P/mL,
b: 1.0×104 P/mL, c: 1.0×104 P/mL, Cu2+ concentrations in 100 µM ). (153Eu, dwell time:
10 ms).
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Figure 33 showed raw spICP-MS data for 10 s of the 180 s acquisition period.
These data demonstrated that the spike number was substantially decreased with the
existence of Cu2+. The increased spike intensity and decreased spike number were also
consistent with mechanism of the aggregation process. These clear different signals
demonstrated the feasibility of spICP-MS detection. In the meanwhile, Figure 34
showed, SPN-Eu emitted fluorescence at 560 nm with the excitation of 480 nm (curve
a). When Cu2+ was added with the SPN-Eu and sonicated for 60 min, the fluorescence
intensity was decreased (curve b), indicating the outstanding fluorescence response to
Cu2+. In contrast, compared with control, a relative high fluorescence intensity was
collected without mixing with Cu2+ (curve a).
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Figure 34. Fluorescence spectra of SPE-Eu under two conditions. (a) SPN-Eu (b) SPNEu + 100 µM Cu2+, λex = 480 nm, λem = 560 nm.
3.4. Optimization of the reaction conditions
The effect of the concentration of SPN-Eu on the fluorescence intensity was
investigated in Figure 35. The fluorescence intensity of SPN-Eu was studied by
measuring the fluorescence intensity of different concentrations of SPN-Eu in the
solution of 100 M of Cu2+ in 10 mM HEPES at pH 7.4. The concentrations of SPN
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were 5.0 ppm, 2.0 ppm, 1.0 ppm, 0.5 ppm, 0.1 ppm and 0.05 ppm respectively. The
fluorescence spectra were recorded in the range of 500 nm to 750 nm using an excitation
wavelength of 480 nm. Fluorescence intensity of the SPN-Eu nanoparticle solution
added with Cu2+ was recorded as F. The fluorescence of the same concentration of SPNEu was defined as F0. In the lower concentration of SPN-Eu, the ratio of F to F0 was
high because of the high background noise comparing to the low fluorescence signal.
In the high concentration of SPN-Eu, the ratio of F to F0 was also high, which is due to
the decreased fluorescence was not significant comparing to the high fluorescence of
SPN-Eu. Therefore, the shape of the curve decreased first and then increased as the
concentration of SPN-Eu enhanced. The corresponding ratios of F to F0 reached
minimum value at the concentration of 1.0 ppm of SPN-Eu, referring to the highest
sensitivity at this concentration. Consequently, we stipulated the concentration of SPNEu to 1.0 ppm for the following experiments.
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Figure 35. The effect of concentration of MEH-PPV-Eu SPN on the sensitivity of the
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sensor. F referred to the fluorescence intensity of different concentrations of SPN
treated with 50 µM Cu2+ in 20 mM HEPEs ( pH 7.0) λex = 480 nm, λem = 560 nm,
reaction time: 5.0 h.
Similarly, the impact of reaction time of Eu-SPN with Cu2+ ions was analyzed
by measuring the fluorescence intensity of different reaction time period of Eu-SPN
added into the solution of 50 µM of Cu2+ in 10 mM HEPES at pH 7.4. The reaction
times were 0.5 h, 1 h, 3 h, and 5 h, respectively. The fluorescence spectra were recorded
in the range of 480 nm to 700 nm using an excitation wavelength of 480 nm. The time
optimization was shown in Figure 36, F0 refers to the fluorescence intensity of 1.0 ppm
of SPN-Eu at various time periods as a control, and F refers to the fluorescence intensity
of 1.0 ppm of SPN-Eu with the addition of 50 µM Cu2+ at various time periods. It was
observed that after 1.0 h the curve has reached a plateau. The following experiments
were run for 1.0 h.
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Figure 36. Time effect on the sensitivity of the MEH-PPV-Eu SPN. F referred to the
fluorescence intensity of different time period of the 1.0 ppm of MEH PPV-Eu SPN
treated with 50 µM Cu2+ in 20 mM HEPEs ( pH 7.0)
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λex = 480 nm, λem = 560 nm.
The pH was also an important factor in the aggregation reactions between the
Cu2+ and nanoparticles. The fluorescence intensity of SPN-Eu mixed with Cu2+ at
different pH conditions were recorded to assess the optimal pH condition. As shown in
Figure 37, F0 refers to the fluorescence intensity of 1.0 ppm of SPN-Eu without Cu2+ in
various pH conditions, and F refers to the fluorescence intensity of 1.0 ppm of SPN-Eu
with 100 µM Cu2+ at corresponding pH conditions. The ratio of F/F0 was decreased as
the pH value was increased from 1.0 to 7.0, indicating the pH-dependent quenching
ability of GQDs. In low pH conditions, the protonation of the carboxylic groups
shielded the SPN-Eu from chelating with Cu2+, therefore the ratio of F to F0 was higher.
In high pH conditions, the ratio of F to F0 was lower because of the stronger interactions
between negative charged carboxylic groups and positive charged Cu2+. Obviously, at
pH 7.0, the fluorescence quenching reached the lowest value. Therefore, the following
experiments were performed at pH 7.0.
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Figure 37. The effect of pH on the sensitivity of MEH-PPV-Eu SPN. F refers to the
fluorescence intensity of the 0.1 ppm of MEH PPV-Eu SPN treated with 50 µM Cu2+
at different pH in 20 mM HEPES, λex = 480 nm, λem = 560 nm, reaction time :1.0 h.
3.5. Sensitivity of SPN-Eu on Cu2+ by fluorescence
To evaluate the fluorescence quenching ability of Cu2+ to SPN-Eu under
optimal conditions, 1.0 ppm of SPN-Eu solution was sonicated with various
concentrations of Cu2+ (0 µM, 2 µM, 5 µM, 10 µM, 20 µM, 40 µM, 50 µM, 60 µM and
80 µM, respectively) for 1 h at room temperature in 20 mM HEPES buffer at pH 7.0.
The corresponding fluorescence intensity was recorded. As the concentration of Cu2+
increased, the fluorescence intensity at 560 nm substantially reduced (Figure 38A).
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The results showed that the dynamic range was from 0 µM L to 80 µM (Figure
38B), with a linear range from 2 µM to 50 µM (the inset of Figure 38B). The calibration
curve showed a regression equation of

Y= −136.5X + 8538 with a correlation

coefficient of 0.9905. The limit of detection (LOD) for the detection of Cu2+ was
calculated to be 0.29 µM based on the slope of the equation (3σ/s), where σ was the
standard deviation of three blank fluorescence intensities and s was the slope of the
calibration curve. This LOD could ensure the detection of Cu2+ in river or drinking
water.
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Figure 38. The effect of various Cu2+ concentrations on the fluorescence intensity of
MEH-PPV-Eu SPN in pH 7.0 10 mM HEPES λex = 480 nm, λem = 560 nm, reaction
time 1.0 h.
3.6. Selectivity of SPN-Eu on various metal ions by fluorescence
A selectivity study for Cu2+ over different metal ions is shown in Figure 39. The same
concentration of Cu2+ and other ions, Ni2+, Co2+, Fe2+, Fe3+, Pb2+, Mg2+, Cd2+, Ag+, Zn2+,
Al3+, Mn2+(50 M), were added into 1.0 ppm of the SPN-Eu solution in pH 7.0, 20 mM
HEPES for 1.0 h. The fluorescence spectra were recorded in the range of 480 nm to 750
nm using an excitation wavelength of 480 nm. F0 refers to the fluorescence intensity of
1.0 ppm of SPN-Eu at various metal ions as a control in the optimal condition, and F
refers to the fluorescence intensity of 1.0 ppm of SPN-Eu with an addition of same
concentration of various metal ions. The results showed a significantly lower
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fluorescence intensity with Cu2+ than with other metal ions.
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Figure 39. Effects of different ions (50 µM) on the fluorescence intensity difference of
Eu-SPN in pH 7.0 for 1.0 h.
3.7. Cu2+ detection in spICP-MS
spICP-MS detection of SPN-Eu on Cu2+ was performed under the same optimized
condition as the fluorescence approach. The feasibility experiments have demonstrated
that the number of SPN-Eu detected during the spICP-MS data collection period (180s)
was decreased as the amount of nanoparticle aggregation enhanced. Therefore, in order
to build the relationship with Cu2+ concentration, the aggregation level was defined as
 in the following equation 1.
Number of SPN~Eu detected 𝐚𝐟𝐭𝐞𝐫 mixed with Cu2+ (𝐸)

φ = 1 − Number

of SPN~Eu detected 𝐛𝐞𝐟𝐨𝐫𝐞 mixed with Cu2+ (𝐸0 )

Eq 1
In Figure 40, the raw spICP-MS data showed a decreased number of individual
spikes in a wide Cu2+ detection dynamic range covering from 1.0×10-3 nM to 1.0×105
nM. In Figure 41, SPN-Eu (1.0 ppm) was reacted with different concentrations of Cu2+
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(0, 0.001, 0.01, 0.1, 1, 10, 100, 1,000, 10,000, 100,000 nM) at the optimized condition.
The aggregation level showed an acceptable regression equation of =
0.08327Log[Cu2+] + 0.3289 for Cu2+ with a correlation coefficient of 0.9944.(Figure
41) The limit of detection (LOD) for Cu2+ was calculated to be 0.42 pM based on the
slope of the equation (3σ/s), where σ was the standard deviation of three blank 
values ,and s was the slope of the calibration curve. In conclusion, this method showed
a broad linear range and a low limit of detection value for Cu2+.
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Figure 40. spICP-MS spectra of SPN-Eu in the presence of different concentrations of
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Cu2+( A to J: 0, 0.001, 0.1, 1, 10, 100, 1000, 10000, 100000 nM). Incubation at 25 °C
for 60 min in HEPES buffer( 20 mM, pH 7.0). Dilution to 1.0×104 particles/mL and
injecting into spICP-MS( 153Eu, dwell time: 10 ms)

Figure 41. Selectivity of the SPN-Eu probe for Cu2+ detection by spICP-MS. Cu2+ and
some other ions’ concentrations: 1 µM.
3.8. Selectivity of SPN-Eu on Cu2+ by spICP-MS
The selectivity of the SPN-Eu probe for Cu2+ was studied using the spICP-MS
assay. SPN-Eu solution was mixed with other relevant metal ions which might be
existing in the natural environment. A series of metal ions was evaluated including
Ni2+, Co2+, Fe2+, Fe3+, Pb2+, Mg2+, Cd2+, Ag+, Zn2+, Al3+, Mn2+, and Cu2+ at a
concentration of 1 µM. The results are shown in Figure 40. The aggregation level  on
Cu2+ was higher than the other monovalent, bivalent and trivalent metal ions. Fe3+, and
Fe2+ showed slight aggregation. However, their value of E/E0 was larger than 80%,
which

exhibited

a

significant

difference
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compared

with

Cu2+.
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Co2+ Fe2+ Mg2+ Pb2+ Fe3+ Cd2+ Ag+

Zn2+ Al3+ Mn2+ Cu2+
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Figure 42. Selectivity of the SPN-Eu probe for Cu2+ detection by spICP-MS. Cu2+ and
some other ions’ concentrations: 1 µM.
3.9. Analysis of the spiked samples
To test the applicability of this Eu-SPN approach for Cu2+ detection, river
water samples were spiked with two different levels of Cu2+ (10 µM and 100 nM),
followed by detecting with both fluorescence signal and spICP-MS signal.
Both fluorescence and spICP-MS detection were performed. The spike
recovery results are compared with the standard traditional ICP-MS method in Table 5.
The higher concentration (10 µM) was in the linear range of the fluorometric method,
the result detected by the fluorometric method showed a correspondent value with ICPMS method. The lower concentration was in the linear range of spICP-MS method.
Both of the results tested by the spICP-MS method and fluorometric method exhibited
acceptable recoveries (100±20%).
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Table 5. Spike recovery level of spICP-MS and fluorometric methods for Cu2+ detection
in river water (n=3).

4. Conclusions
In this chapter we developed a two-readout nanoprobe for Cu2+ detection by
Eu3+ doped MEH-PPV semiconducting polymer nanoparticles. The strong chelating
interactions between carboxylic groups and Cu2+ induced the aggregation, which could
be analyzed by both fluorescence and spICP-MS signal. This method has substantially
enhanced the sensitivity and reduced limit of detection for copper detection. The spICPMS method showed a broad logarithmic range of 0.001 nM to 100,00 nM with a limit
of detection of 0.42 pM. In contrast, the fluorescence method showed a linear range of
2 µM to 50 µM with a limit of detection of 0.29 µM. The developed probe was
successfully used for Cu2+ detection in river water with acceptable recovery results.
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